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ABSTRACT 
 This dissertation comprises four projects. I) Glycosylation is a post-translational 
modification that affects many physiological processes, including protein folding, cell 
interaction and host immune response. PglC, a phosphoglycosyl transferase (PGT) 
involved in the biosynthesis of N-linked glycoproteins in Campylobacter jejuni, is 
representative of one of the structurally simplest members of the small bacterial PGT 
family. The research utilizes sequence similarity network and evolutionary covariance 
studies to identify the catalytic core of PglC, followed by modeling its three-dimensional 
structure using the covariance as constraints. II) Rapid growth of fragment-based drug 
discovery necessitates accurate fragment library screening for targets of interest, finding 
strong binders with specific binding. While many high-resolution biophysical methods 
for fragment screening work well, docking-based virtual screening is highly desired due 
to the speed and cost efficiency. Beyond the key performance-determining factors like 
score function and search method, the goal is to learn from the experimental fragment 
bound structures in the PDBbinder database and to evaluate the profile of side-chain 
flexibility in the interface and its contribution to docking performance. III) Protein 
docking procedures carry out the task of predicting the structure of a protein–protein 
  vii 
complex starting from the known structures of the individual protein components. 
However, the structure of one or both components frequently must be obtained by 
homology modeling based on known structures. This work presents a benchmark dataset 
of experimentally determined target complexes with a large set of sufficiently diverse 
template complexes identified for each target. The dataset allows developers to test their 
algorithms combining homology modeling and docking, in order to determine the factors 
that critically influence the prediction performance. IV) Human Eukaryotic Initiation 
Factor 4AI (heIF4AI) is the enzymatic component of a highly efficient complex, heIF4F. 
Its helicase activity binds and unwinds the secondary structure of mRNA at the 5' end and 
thus plays a crucial role in translation initiation. This research focuses on the C-terminal 
domain of heIF4AI and investigates its potential as an anti-cancer target by integrating 
the approaches of solvent mapping, docking, crystallization and NMR. 
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CHAPTER ONE  
Conservation and Covariance in Small Bacterial Phosphoglycosyltransferases 
Identify the Functional Catalytic Core 
1.1 Introduction 
  Phosphoglycosyltransferases (PGTs) make up a family of enzymes that catalyze 
the transfer of a sugar 1-phosphate from a nucleotide-activated donor to a polyprenol 
phosphate acceptor substrate. This family encompasses the previously described 
polyisoprenyl-phosphate hexose-1-phosphate transferase (PHPT) and polyisoprenyl-
phosphate N -acetylaminosugar-1-phosphate transferase (PNPT) family enzymes.(3, 
4)  The products of PGT reactions are elaborated into complex polyprenol-diphosphate-
linked glycans, which serve as glycosyl donors in pathways such as those in the 
biosynthesis of glycoproteins and glycolipids. Although most identified PGTs are 
bacterial, there are important eukaryotic members such as Alg7, which initiates the N-
linked protein glycosylation pathway in eukaryotes from yeast to man, by catalyzing the 
biosynthesis of dolichol-PP-GlcNAc.(5) 
PGTs catalyze interfacial reactions between a soluble sugar substrate and a 
membrane-bound polyprenol phosphate to form a membrane-bound product (Scheme 
1.1). PGTs are integral membrane proteins and can be organized into subfamilies based 
on their membrane topologies. The best known PGTs include members of the WecA and 
MraY subfamilies. (4)  These are polytopic membrane proteins with ≥ 10 transmembrane 
helices (TMHs) (Figure 1.1 A, B). To date, the only PGT with a known three-
dimensional structure is MraY from Aquifex aeolicus.(6)  On the basis of conservation 
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analysis together with the crystal structure, the active site of MraY was predicted to 
include three conserved aspartate residues and one conserved histidine residue. 
Mutagenesis of each of the three aspartate residues to asparagine eliminates translocase 
activity in MraY.(7) 
 
 
 
Scheme 1.1 Phosphoglycosyltransferase Reaction Shown with a Generic UDP-
Carbohydrate Substrate and Membrane-Bound Undecaprenol Phosphate 
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Figure 1.1 Predicted and experimentally determined membrane topologies of 
phosphoglycosyltransferase (PGT) families. The soluble C-terminal PglC-like domain 
is colored red. 
In conjunction with studies of prokaryotic protein glycosylation, a distinct 
structural family of prokaryotic PGTs has been identified, which is typified by the 
Campylobacter jejuni PGT known as PglC. PglC catalyzes the reaction between UDP-
diNAcBac and undecaprenol phosphate, forming undecaprenol-P-P-diNAcBac with the 
release of UMP as a byproduct. (8)  Homologues of PglC are predicted to be type I 
membrane proteins with monotopic structures characterized by a short N-terminal 
periplasmic domain, a single predicted TMH, and a soluble globular C-terminal domain 
located in the cytosol (Figure 1.1 C). (8)  In contrast to the polytopic PGTs, including 
MraY and WecA, the PglC subfamily of PGTs is small (approximately 200 amino acids 
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in length), and although they perform similar chemical transformations, they do not share 
significant sequence identity or possess any of the identified consensus motifs found in 
the larger PGTs. Functional and bioinformatics analysis in our laboratories (9) as well as 
that by the Valvano group (10, 11) reveals two other related families, which include the 
primary sequence of the globular cytosolic domain of PglC-type PGTs embedded into a 
more complex framework (Figure 1.1 C−E). One of these families is typified by the 
bifunctional PglB (Ng) from Neisseria gonorrheae , which features an N-terminal PGT 
domain, (9)  with a high degree of sequence identity (53%) to the C. jejuni  PglC, and a 
C-terminal amino-sugar acetyltransferase domain that catalyzes acetylation of the UDP-
4-amino sugar precursor to UDP diNAcBac. (9)  The second related family is 
exemplified by WbaP from Salmonella enterica. WbaP catalyzes the transfer of galactose 
1-phosphate from UDP-Gal to undecaprenol phosphate. (10-12) Enzymes in this family 
are polytopic, with five to seven predicted TMHs; (13) however, several of the N-
terminal helices are not essential for PGT activity. (12-14) The functional C-terminal 
domain comprises a predicted membrane-bound hydrophobic sequence and a cytosolic 
globular domain, which has a sequence that is 34.7% identical to that of C. jejuni PglC. A 
recent study with WcaJ, an Escherichia coli enzyme that is a member of the WbaP 
family, used PhoA/LacZ fusions and cysteine labeling to investigate the cellular 
localization of loops and the globular domain. (13) The results of this study suggest that 
the predicted TMH adjacent to the C-terminal globular domain is actually a re-entrant 
helix, forming a hairpin bend in the membrane, rather than spanning the membrane 
(Figure 1.1 E). At present, similar experimental studies have not been performed with 
  
5 
PglC-like or bifunctional PglB-like PGTs, and therefore, the topological models 
illustrated in panels C and D of Figure 1.1 are based solely on TMH predictions. Herein, 
sequence analyses were used to gather the related cytosolic globular domains in all three 
small bacterial PGT families: PglC-like, bifunctional PglB-like, and WbaP-like. The 
resulting sequence alignments allowed the identification of highly conserved residues, 
and construction of a structural model utilizing three-dimensional distance constraints 
was achieved via covariance analysis. The conserved amino acids and the model together 
identified residues, which were validated by site-directed mutagenesis as being critical 
for catalytic activity. In addition to the TMH, the predicted secondary structural features 
are consistent with the presence of a second highly conserved helix. The application of a 
helical wheel plot to this helix suggests a pattern of hydrophobicity consistent with 
placement at the protein− membrane interface or within a protein-docking interface. 
Together, these studies yield insight into the relationship between distant families that 
catalyze the phosphoglycosyltransferase reaction, identify and confirm catalytically 
essential amino acids, and begin to elucidate the structure− function connections in small 
bacterial PGTs. 
 
1.2 Materials and Methods 
 Construction of the Sequence Similarity Network.  
Three programs (TMHMM, (15) MEMSAT, (16) and TOPPRED (17) were used 
to identify potential transmembrane helices (TMHs) in full length C. jejuni PglC. A 
sequence similarity network was generated for each of the three families of PGTs, as well 
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as a final alignment including all three families (see Figure 1.2 A for details). For each 
family, the soluble C-terminal phosphosugar transferase domain sequence (without the 
predicted TMH) was extracted and used as the query sequence in BLAST against the 
UniprotKB database. A set of 15000 potential homologous sequences were retrieved and 
used as the input to construct a sequence similarity network. All sequences that 
were >65% identical (resulting in 4554 sequences for all three families) were clustered 
using CD-HIT (18) and represented by a single representative sequence. A sequence 
similarity network was built from the set of pairwise relationships denoted by the e-value 
for each of the three PGT families and visualized using Cytoscape (Figure 1.6). Under a 
strict e-value cutoff of 1x10−50, the numbers of nodes in both gross and direct 
neighboring child networks are summarized in Table 1.1. On the basis of the similarity 
network, a stringent set of homologous sequences was parsed out by selecting the original 
target and the neighboring nodes with direct links to the target. The selected sequences 
were used to generate a high-quality multiple-sequence alignment (MSA) and to develop 
a final MSA, including all three families. The MSAs were further edited to remove gaps 
and subjected to sequence logo construction through WebLogo 3. (19) 
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Figure 1.2 Flowchart of: (A) Sequence Similarity Network Construction and 
Conservation Analysis and (B) EVFOLD modeling. 
 
Evolutionary Coupling Analysis and Structure Modeling.  
The web server EVFold, developed for evolutionary coupling analysis-based de 
novo structural modeling, (20) was used to predict the structures of the C. jejuni PglC C-
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terminal soluble domain (see Figure 1.2B for the outline of the method). The server 
extracts a large number of homologous sequences from the corresponding protein family 
and uses a global maximum entropy model-based algorithm, EVCoupling, (20) to predict 
a set of “direct” residue couplings that are likely to represent spatial proximity. A subset 
of high-scoring residue pairs is converted to “evolutionary inferred contacts” (EICs) and 
utilized to predict three-dimensional structures. Because the number of distance 
constraints is a critical parameter for accurate model generation, for each system, only 
those models with an adequate number of EICs (at least half of the total number of 
residues) are retained. The reliability of the approach was evaluated by application to two 
proteins with known structures and similar in size to PglC, 6-hydroxymethyl-7,8-
dihydropterin pyrophosphokinase, and human macrophage elastase (see Supporting 
Methods). To assess the reproducibility of the structure prediction, the homology 
modeling server I-TASSER was also used to model the soluble domain of C. jejuni PglC 
with the same set of top 80 ranked EICs from EVfold as restraints. 
 
1.3 Results and Discussion 
 Identification of Conserved and Functional Residues. The functional and 
mechanistic similarity of the reactions catalyzed by the PglC-type PGTs accompanied by 
bioinformatics analysis (9, 11) suggested that the PglC-like, bifunctional PglB-like, and 
WbaP-like subfamilies could be grouped into one family of PGTs and that conservation 
analysis could be utilized to identify critical residues. To this end, an alignment of 984 
sequences [those sequences in the direct neighboring child network (see Table 1.1)], 
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using one query sequence from each of the subfamilies of the small bacterial PGTs 
(Uniprot entries E8SR45, U6QR91, and O86156), was utilized to generate a multiple-
sequence alignment (MSA), revealing that ∼ 25% of the sequence is conserved. After the 
sequences had been edited to remove gaps, this high-quality MSA of the globular C-
terminal domain from the PglC-like and WbaP-like PGT families, and the homologous 
domain in the bifunctional PglB-like family, was utilized to generate a sequence logo to 
display the patterns in the aligned sequences. The sequence logo of the small bacterial 
PGT families reveals highly conserved residues that would not have been apparent from 
alignments of any of the sub-families individually (Figure 1.3). The conserved residues 
were compared to those previously identified for the WecA and MraY families of PGTs 
via bioinformatics and mutagenesis as being implicated in substrate binding and catalysis. 
(4, 6, 7, 21-24) Notably, the conserved WecA and MraY family motifs were not observed 
in the MSA of the small bacterial PGTs, confirming that these PGTs form distinct 
structural classes. Identification and delineation of the margins of any transmembrane 
segments and soluble domain(s) of the C. jejuni PglC was performed via prediction and 
topology algorithms (see Materials and Methods). For PglC, a single N-terminal TMH 
was predicted; thus, residues 34− 200 comprise a soluble domain. Guided by the margins 
of the predicted TMH and the MSA, our collegue, we selected conserved residues for 
analysis by site-directed mutagenesis in the full length PglC from C. jejuni. To notify, all 
the experiments including protein expression/purification, mutagenesis analysis and 
enzymatic activity assay, were done by Vinita Lukose from Professor Barbara Imperiali 
lab. The selections for site-directed variants included highly conserved aspartate and 
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glutamate residues (D92, E93, D156, and D168) as these residues typically coordinate 
metal ion cofactors and have additionally been identified as potential active site residues 
in the WecA and MraY families of PGTs. (7, 25) Also targeted were conserved arginine 
residues (R87 and R111), which may be involved in interactions with the phosphate 
groups of substrates and products, and a conserved methionine residue (M62). In 
addition, we identified a conserved proline in the TMH (C. jejuni  PglC P24); the 
presence of a Pro in the center region of the membrane-bound sequence that is N-terminal 
to the globular domain has also been noted previously in the WbaP-like family PGTs. 
(13)  In our study, the extensive alignment pool provided insight into the identity of other 
residues that might be featured in this site of the protein and that might be investigated to 
assess the significance of the secondary amino acid, proline, in enzyme function. Finally, 
two nonconserved glutamate residues (E65 and E116) were mutated to glutamine, as 
controls for mutagenesis analysis. 
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Figure 1.3 Sequence alignment of the PglC-like domain from the PglC, PglB(Ng), 
and WbaP families of PGTs. The alignment was visualized using WebLogo 3. 12 
Residues indicated with a red line were analyzed by site-directed mutagenesis and are 
marked above the red line using the C. jejuni (NCTC 11168) PglC numbering system. 
 
  The wild type and variants of the C. jejuni PglC were expressed as SUMO fusions 
to aid in maintaining protein solubility during expression and purification. The SUMO 
tag greatly improved the solubility of PglC relative to that of the wild-type construct, and 
the SUMO-PglC fusion protein exhibited catalytic activity that did not significantly differ 
from that of the wild-type enzyme. Enzyme activity was quantified by applying a 
radioactivity-based extraction assay using undecaprenol phosphate and 3H-labeled UDP-
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diNAcBac. Purified PglC variants were tested at up to 100 times the concentration of the 
wild-type enzyme to increase sensitivity toward low-activity samples. 
Deletion studies have been used previously to provide insight into the importance 
of the transmembrane domains in many families of PGTs. For example, WbaP expressed 
without the first four predicted transmembrane helices is still catalytically 
active.(12) Importantly, replacing the fifth predicted TMH of WbaP with the first TMH 
in the sequence resulted in a nonfunctional protein, suggesting that the specific identity of 
the TMH is critical for catalysis.(11) The PGT alignment presented here revealed that 
proline is highly conserved at position 12/13 of the TMH in 95% of the PGTs in the 
analysis. This conserved proline has also been previously identified in a homologous 
position in the WbaP family of PGTs.(13) The conserved proline (P24) in the C. 
jejuni  PglC is part of a sequence (FILALVLLVLFSPVILITALLL) that is reminiscent of 
the polyisoprene recognition sequence (PIRS), LL(F/I)IXFXXIPFXFY, identified in 
other enzymes that process polyprenol phosphate-linked substrates, as the PIRS 
sequences also include a centrally located proline residue.(6, 26) Additionally, a 
tryptophan is shown for the first time to replace this proline residue in approximately 5% 
of the PGT sequences in the analysis. Therefore, in the mutational analysis, Pro24 was 
replaced with both alanine and tryptophan to assess the importance of the proline and to 
observe whether tryptophan represents a functionally conservative substitution. Indeed, 
the P24A variant showed no activity; however, the P24W variant retained measurable 
activity, although at levels lower than that of the wild-type enzyme (Table 1.4). A helix-
breaking proline has also been identified at a similar position (residue 12/13) in a 
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transmembrane helix (residues 413− 432) of the Campylobacter lari oligosaccharyl 
transferase PglB, which has recently been structurally characterized. PglB uses 
undecaprenol diphosphatelinked oligosaccharide as its substrate, suggesting that this 
structural feature may be a binding determinant for the undecaprenol moiety.(27) While 
additional studies are clearly needed to further this hypothesis, analysis of the interactions 
of Pro-, Trp-, and Ala-containing TMHs with undecaprenol phosphate will be of 
considerable interest. 
Mutagenesis analysis of the conserved arginine residues, Arg87 and Arg111, 
resulted in catalytically inactive PglC. These positively charged residues may interact 
with the negatively charged phosphate groups of the substrates and products of this 
reaction or may participate in salt bridges required to maintain the structure of PglC. We 
also investigated the role of the conserved methionine residue M62, hypothesizing that it 
may play a role in maintaining protein structure. When it was replaced with glutamine, 
activity decreased significantly to approximately 1% of native levels. However, the more 
conservative mutation to isoleucine preserved activity at approximately 10% of that of 
the wild-type enzyme (Table 1.4). 
Aspartic acid residues are implicated in metal-ion cofactor coordination in the 
WecA and MraY families of proteins.(25) Sequences in both families contain adjacent 
aspartic acid residues (D90/91 in E. coli  WecA and D115/D116 in E. coli MraY). The 
adjacent aspartate residues resemble the conserved DDXXD motif found in other 
enzymes with diphosphate substrates, such as prenyl transferases, where the DD pair 
coordinates the Mg2+  cofactor.(28) The WbaP family does not contain this DD motif but 
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does possess adjacent aspartate and glutamate residues (D382/E383); their mutation 
abolishes enzyme activity.(10)  The PGT sequence alignment in this study (Figure 1.3) 
highlighted a similar sequence, corresponding to residues D92 and E93 in PglC. 
Mutational analysis showed a complete loss of activity when E93 was replaced with 
glutamine, which replaces steric but not electronic properties. However, in the case of 
D92, the D92N variant failed to express at a useful level (data not shown), and thus, the 
D92A variant was constructed. Although this protein expressed at wild-type level, it was 
prone to aggregation during solubilization and therefore was analyzed as the CEF. This 
approach was adopted because in general we have observed that extracting protein from 
the CEF into detergent micelles during purification can contribute significantly to protein 
instability in vitro. The D92A variant showed no activity even at protein concentration 
levels >100-fold greater than that of the CEF with the wild-type protein [based on SDS− 
PAGE analysis (Table 1.4)]. 
In addition to D92, two other aspartic acid residues, D156 and D168, were found 
to be strictly conserved and were also selected for mutagenesis because these might play 
key roles in catalysis. For example, aspartate residues may play a nucleophilic role in 
PGTs, and it has been proposed that a conserved aspartic acid residue in the fourth 
cytoplasmic loop of MraY is a nucleophile that initiates the PGT reaction by forming a 
covalent phosphosugar− enzyme intermediate.(7) Attempts to express and purify D156A 
and D168A variants yielded results similar to those for the D92A mutant, and therefore, 
the D156A and D168A variants were prepared and analyzed as CEFs. Replacement of 
either of these aspartic acid residues with alanine resulted in the complete loss of activity. 
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Because of the poor stability properties of these enzymes, it is not yet clear whether the 
mutations of D156 and D168 altered the catalytic properties of the enzyme in a specific 
way by eliminating key acidic residues that are essential for catalysis or whether the loss 
of activity was due to a major structural perturbation. 
The only branch of the minimal monotopic PGT family on which a bioinformatics 
analysis has been performed previously is that typified by the C-terminal domain of 
WbaP from S. enterica (Figure 1.1). The study compared several hundred WbaP 
homologues to identify conserved residues.(10)  The most conserved charged or polar 
amino acids were mutated to alanine residues, and variant proteins were evaluated using 
in vivo  complementation assays to observe the formation of LPS O-antigen. There is 
overlap in the conserved residues discovered in those experiments and herein. Both 
studies identified the adjacent Asp-Glu pair (D92/E93 in C. jejuni PglC) as being critical 
for activity, as well as an additional conserved aspartate residue (D168 in PglC, 
corresponding to D458 in WbaP). Additionally, the studies also revealed a homologous 
arginine residue (R111 in PglC, R401 in WbaP) that is essential for catalysis. 
 
Evolutionary Couplings and Structure Prediction. On the basis of conservation 
covariance, a predicted three-dimensional structure was constructed for the soluble 
domain of PglC (see Materials and Methods). The main tool is the EVfold method, which 
uses multiple sequence alignments and a maximum entropy model of the protein 
sequence to obtain direct residue pair couplings that might represent spatial proximity. 
The couplings are used to calculate residue−residue proximity in folded protein structures 
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in conjunction with distance constraints, secondary structure predictions, and molecular 
dynamics simulations, to yield predicted structures. Seven thousand PGT globular 
domain sequences were used to generate predicted co-varying residues and structures of 
PglC in EVfold. The TMH was not included in the modeling, and the prediction was 
limited to the soluble domain in all cases. The multiple-sequence alignment for the last 
20 residues was of poor quality because of the large number of gaps (lack of 
information); therefore, this segment appeared as an unstructured loop in the predicted 
model from EVfold. Because the number of distance constraints is a critical parameter in 
the generation of an accurate model, especially when there is not a native structure 
available for comparison, the only models kept were those with more than 80 
evolutionarily inferred contacts (EICs) (half of the protein length). If the top-ranking 
model (Figure 1.4A) is used as the putative native structure, the root mean-square 
deviation (RMSD) value of that model compared to the other top 10 models ranges from 
4.4 to 7.5 Å (Table 1.2), with only two exceptions (11.4 and 12.7 Å). These top models 
are comparable to the control models generated for proteins of known structure in terms 
of model consistency, which lends confidence to the predicted PglC structure. 
To control for the uncertainty inherent in computational modeling approaches, the 
program suite I-TASSER was also used to model the three-dimensional structure of 
soluble PglC (see Experimental Procedures). I-TASSER is a threading (fold recognition)-
based structure prediction method, which differs from the distance geometry-based 
method in EVFold. Using the same set of EICs, the best model (largest structure cluster) 
from I-TASSER is very similar to the EVFold model in both the tertiary structure (rmsd 
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= 4.7 Å) and the local spatial arrangement of all those conserved, functionally critical 
residues (Figure 1.4B). This lends support for these models. Many of the residues 
identified as being important for catalysis were found in the model proximal to one 
another, suggesting they may be involved in substrate binding (Figure 1.4A). To examine 
whether the distances between these residues are realistic with respect to the size of the 
soluble substrate UDP-Bac, we compared selected inter-residue distances and the overall 
dimensions of UDP-Bac (Protein Data Bank entry 3BSS). The distance between D92 
(Cα) to D156 (Cα) is 12.4 Å and that between D92 and D168 16.4 Å compared to that of 
the extended conformer of UDP-Bac (14.0 Å). Additionally, the non-conserved residues 
used as controls in our mutagenesis studies were distal to the predicted active site of the 
protein. Notably, a search of the structural database using the similarity server 
DALI29 with the predicted PglC three-dimensional structure did not find any structural 
homologues. The segment between residues 160 and 180 in the PglC model (the C-
terminal helix) was predicted to be a hydrophobic helix in the three-dimensional structure 
models (Figure 1.5A). However, on the basis of multiple programs (see Materials and 
Methods), the helix is not predicted to be transmembrane. To further investigate the role 
of the C-terminal helix, the sequence was input into a helical wheel projection tool, 
(1)  showing it to have two hydrophobic surfaces (Figure 1.5B). The three-dimensional 
model predicts that this segment forms an α -helix, in which hydrophobic residues line 
one face of the helix facing away from the protein core and a second group of 
hydrophobic residues pack toward the protein core (Figure 1.5A). It is possible that such 
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a helix provides a face for interacting with the membrane surface or for acting as the 
interface in a protein− protein interaction. 
 
 
 
Figure 1.4 Predicted structure of the soluble domain of PglC. (A) Stereoview ribbon 
diagram of the highest ranked predicted structure from EVfold showing residues mutated 
in this study. Conserved residues are colored orange, and nonconserved residues are 
colored green. (B) Superposition of the best models generated by EVfold (blue ribbon) 
and I-TASSER (yellow ribbon). 
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Figure 1.5 Structure of the predicted hydrophobic helix in PglC. (A) Focused view of 
the predicted hydrophobic helix shown in the highest ranked model structure from 
EVfold, with surface-exposed hydrophobic residues represented as sticks. (B) Helical 
wheel predicted for the hydrophobic helix. (1) The most hydrophobic residue is colored 
green, and the amount of green decreases proportionally to the hydrophobicity, with zero 
hydrophobicity colored yellow. Hydrophilic residues are colored red, with pure red being 
the most hydrophilic (uncharged) residue. 
 
Protein BLAST and Construction of Sequence Similarity Network  
Figure 1.2A shows the steps of the analysis. Uniprot IDs U6QR91, O86156 and 
E8SR45 were used as representative sequences of the three PGT families for the analysis. 
For each family, the TMHs or transmembrane regions sugar transferase domain sequence 
was detected using the TMHMM server (http://www.cbs.dtu.dk/services/TMHMM/). 
Then, the soluble C- terminal phosphosugar transferase domain sequence (without the 
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predicted TMH) was used as the query sequence in BLAST against the UniprotKB 
database (http://www.uniprot.org/help/uniprotkb), including the sequences both in 
UniProtKB/Swiss-Prot and UniProtKB/TrEMBL. A set of 15,000 potential homologous 
sequences were retrieved for each family and used as the input to construct a sequence 
similarity network. Each set of homologous sequences from BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) was subjected to an all-by-all BLAST to acquire 
the set of pairwise relationships denoted by e-value. In order to reduce redundancy, CD-
HIT(18) (http://bioinformatics.org/cd-hit/) a sequence clustering algorithm was applied to 
cluster all sequence hits based on sequence-identity level. All sequences sharing greater 
than 65% identity were clustered and represented by a single representative sequence. A 
sequence similarity network was visualized from the output of BLAST/CD-HIT for each 
of the three PglC families using Cytoscape. (29, 30) (http://www.cytoscape.org). The 
resulting plots are shown in Figure 1.6. Under the strict e-value cutoff of 1x10-50, the 
number of nodes in both gross and direct neighboring child network are summarized in 
Table 1.1. 
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Figure 1.6 Cytoscape View of Sequence Similarity Network for 3 different PglC 
families in (A) C. jejuni (Uniprot ID: O86156); (B) N. gonorrhoeae (Uniprot ID: 
E8SR45); (C) S. enterica subsp (Uniprot ID: U6QR91). In each panel, the left half 
represents the gross sequence similarity network with a strict e-value cutoff of 1x10-50, 
while the right half represents the child network of nodes bearing direct relations to the 
corresponding original target node (marked as a magenta square) 
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Table 1.1 Summary Table of Sequence Similarity Networks for the three families of 
PglC. The number of nodes in the gross networks are reported, with the numbers inside 
parentheses representing the counterparts in the direct neighboring child network. 
 
Analysis of Sequence Conservation 
In Cytoscape for each family containing a PglC-like domain, a stringent set of 
homologous sequences was parsed out from its network by selecting the original target 
and the neighboring nodes with direct links to the target. The program Clustal Omega 
(31), available as a server at (http://www.ebi.ac.uk/Tools/msa/clustalo/), was used to 
generate a high-quality multiple sequence alignment (MSA) of the soluble, sugar 
transferase domain for the stringent set of homologous sequences from each family and 
the set generated by mixing all three families of PGTs to afford the final “monotopic 
PGT” MSA. The MSAs were further edited to remove gaps, and subjected to sequence 
logo construction through WebLogo (30, 32) available at 
(http://weblogo.threeplusone.com/create.cgi) Conserved residues were color and label 
mapped onto the top EVFold model to visualize their spatial arrangement. 
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Evolutionary Coupling Analysis and de novo Structure Modeling of C. jejuni PglC 
Transmembrane helix prediction. Potential transmembrane helices (TMHs) in full length 
C. jejuni PglC were detected and the start and end residues identified using the prediction 
and topology algorithms TMHMM(15) (http://www.cbs.dtu.dk/services/TMHMM/), 
HMMTOP(33) (http://www.enzim.hu/hmmtop/), DAS(34) 
(http://www.sbc.su.se/~miklos/DAS/), MEMSAT(35) 
(http://bioinf.cs.ucl.ac.uk/psipred/?memsatsvm=1), SPLIT(36) 
(http://split4.pmfst.hr/split/4/), and TMPred 
(http://www.ch.embnet.org/software/TMPRED_form.html). The outputs from these 
programs were compared to ensure the reproducibility of the results. 
 
Model construction. The web server EVFold for evolutionary coupling analysis-based de-
novo structural modeling (20) (http://evfold.org/evfold-web/evfold.do) was used to 
predict the structures of both the C. jejuni PglC soluble domain (i.e. not including the 
TMH) residues 34-200, and two control models generated for proteins of known 
structure. HHblits, a fast HMM-HMM alignment-based iterative protein sequence 
searching method4 built into EVfold was used to acquire a sufficient number of 
homologous sequences where an accurate alignment was built. After the coverage/gap 
filtration step, the MSA was subjected to a global maximum entropy model-based 
algorithm, EVCoupling (20) to achieve a set of ‘direct’ residue couplings, which are 
highly likely to represent spatial proximity. A subset of high-scoring residue pairs was 
converted to “evolutionary inferred contacts” (EICs), which were then utilized by a 
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distance- geometry and simulated annealing based approach, CNSsolve (37) to predict 
three-dimensional structures. Since the number of distance constraints is a critical 
parameter for accurate model generation, for each system, only those models with an 
adequate number of evolutionary inferred contacts (at least half of the total number of 
residues) were retained for subsequent evaluation. 
 
Model evaluation. The accuracy of the three-dimensional structure prediction was 
evaluated using the PyMOL “align” routine. The routine reports the Cα-RMSD and 
number of residues aligned with a distance cut off of 2 Å, for a trimmed set of residues 
after iteratively removing the outlier pairs from consideration, until an optimal 
superimposition is reached between model and reference structure. Coverage of 
alignment was calculated as the percentage of the aligned portion out of the entire 
protein. The two control proteins have known X-ray crystal structures with which to 
compare, while C. jejuni PglC has no three-dimensional structure information available. 
We circumvented this problem by treating the predicted top ranked C. jejuni PglC model 
as the putative native structure. 
To test the ability to reproduce the model with a different algorithm we used the I- 
TASSER (38) server (http://zhanglab.ccmb.med.umich.edu/I-TASSER/), implementing 
an iterative threading assembly homology modeling method, to model the soluble domain 
of C. jejuni PglC with the same set of top 80 ranked EICs from EVFOLD as restraints. 
The global structure similarity between the best I-TASSER model and the best EVFold 
model, was assessed using the PyMOL ‘align’ routine (Table 1.2). 
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Validation of structure prediction using EVFold. As a control for the prediction, two 
structurally characterized proteins, 6-hydroxymethyl-7,8-dihydropterin 
pyrophosphokinase (HPPK; Uniprot P26281) and human macrophage elastase (Uniprot 
P39900), similar in both size and fold type to PglC, were modeled. The top 10 blindly-
ranked model structures have coordinate errors from 2.9 Å to 3.4 Å for HPPK with at 
least 79.2% of the residues aligned, using the ‘align’ module in PyMOL (Table 1.3). For 
elastase, there is slightly worse overlap with coordinate error ranging from 3.9 Å to 7.5 
Å, and at least 69.0% of the residues aligned (Table 1.3). With the level of residue 
coverage in the alignment between the top ranked structure models and the native crystal 
structure in the control structures, it is highly likely that the correct fold can be identified 
successfully for a protein of the size of PglC (160 residues). The resulting predicted 
structures were very similar to the experimentally observed structures with 3-5 Å RMSD 
(on Cα atoms). 
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Table 1.2 Geometric distances of top ten ranked EVFold models and best I-TASSER 
model from the best EVFold model for PglC in C. jejuni. 
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Table 1.3 Assessment of EVFold prediction accuracy for two control models 
generated for proteins of known structure. Top 10 rank EVFold models for 6-
hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK; Uniprot, P26281) and 
human macrophage elastase (Uniprot P39900) are compared to their corresponding native 
structures to show the accuracy of EVFold prediction in terms of both the distance and 
coverage of good alignment between predicted models and native structure. 
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Figure 1.7 Accuracy of the top 3 models of 6-hydroxymethyl-7,8-dihydropterin 
pyrophosphokinase (HPPK) from EVFold. The native structure (PDB: 1IM6; Uniprot 
ID: P26281) is shown in green. The top 3 ranked models are respectively superimposed 
with the native structure with the model rank #1 (pink) in (A), #2 (magenta) in (B) and #3 
(cyan) in (C). 
 
 
Figure 1.8 Accuracy of the top 3 models of human macrophage elastase from 
EVFold. The native structure (PDB: 1JK3; Uniprot ID: P39900) is shown in green. 
Models in other colors represent the predicted ones. The top 3 ranked models are 
respectively superimposed with the native structure with the model rank #1 in (A, pink), 
#2 in (B, magenta) and #3 in (C, cyan). 
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Figure 1.9 Top 3 models of C. jejuni PglC from EVFold. The top 3 models generated by 
EVFold are aligned in PYMOL with rank#1, green; rank#2, cyan; rank#3, magenta. 
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Table 1.4 Summary of Activities of PglC Variants. aAll assays were performed under 
identical conditions with the substrate concentrations set at the KM values: 16 µM Und-P 
and 7.5 µM UDP-diNAcBac. Runs for entries 1−10 were conducted with solubilized and 
purified enzyme, and runs for entries 11−13 were conducted with CEF. bThe wild-type 
level of activity in the presence of 3 nM enzyme, to which all mutant enzymes are 
compared, is defined as +++. A designation of ++ represents the activity of a mutant 
enzyme that attains ∼85% of wild-type activity with 30 nM enzyme. A designation of + 
represents the activity of a mutant enzyme that attains ∼85% of wild-type activity with 
300 nM enzyme. A designation of – is used to describe the activity of a mutant enzyme 
that attains <30% of wild-type activity with 300 nM enzyme. cFor those variants labeled 
(CEF), wild-type levels of activity are designated as +++. For mutant enzymes exhibiting 
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<30% of the wild-type levels of activity with 100-fold more CEF than wild-type enzyme 
as estimated by gel densitometry analysis, this level of activity is designated as −. 
 
1.4 Conclusion 
Proteins that span the membrane once, while abundant in nature (50% of integral 
membrane proteins), have proven to be relatively intractable to structural methods. Key 
issues have recently been highlighted in a paper by Stroud and coworkers. (39)  The 
difficulties lie in the need for a membrane surrogate in solution-based methods (nuclear 
magnetic resonance) and in the problems with ordered crystallization (in X-ray 
crystallography). These methods may suffer from the lack of order normally imposed by 
interaction with membrane and, indeed, the lack of the intermembrane portion of the 
protein, which is often truncated to provide the more soluble, tractable construct. In the 
absence of a structural analysis, bioinformatics in concert with biochemical structure− 
function analysis provides a powerful approach for guiding definition of the catalytic core 
of the small bacterial PGTs discussed herein. The sequence analysis was greatly 
improved by including the corresponding globular domains of PGTs of the PglC-like, 
bifunctional PglB-like, and WbaP-like families, as the alignment of all three groups 
emphasized residues that may not have been revealed by analyzing the sequences of the 
PglC-like family alone. Residues identified from this analysis correlate to residues 
proximal to one another in the predicted model, suggesting that they may participate in 
the activity of the enzyme. The diversity of PGT structures highlights intriguing 
questions concerning the evolution of PGTs in prokaryotes. All of the enzymes catalyze 
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essentially the same reaction, formation of a polyprenol diphosphate-linked glycan by the 
reaction of a polyprenol phosphate with a UDP-sugar as a sugar−phosphate donor, yet the 
topologies supporting the catalytic cores are disparate. This analysis now sets the stage 
for future structural and functional investigations of the smallest bacterial PGTs, which 
will ultimately provide insight into the entire phosphoglycosyl transferase 
family of enzymes that perform this first committed step in many membrane-associated 
glycan assembly pathways. 
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CHAPTER TWO 
A Benchmark Testing Ground for Integrating Homology Modeling and Protein 
Docking 
2.1 Introduction 
The performance of computational protein docking methods1 has significantly 
improved in recent years, as witnessed by the results of CAPRI (Critical Assessment of 
Predicted Interactions), a community-wide experiment for objectively assessing progress 
in these methods.(40) Available docking procedures are increasingly successful in 
accurately predicting the structure of a protein complex starting from the known 
structures of the free monomers (unbound–unbound docking), when the latter undergo 
limited conformational changes upon association. (40)  
However, experimentally determined 3D structures are currently available for <1 
out of a thousand proteins with known amino acid sequence information. On the other 
hand, analyses of protein structures determined so far revealed that these structures 
represent variations around common themes, or proteins folds, that the repertoire of such 
folds is limited, (41) and that this repertoire has essentially been mapped out in recent 
years notably by structural genomics efforts.(42) This has brought to the forefront the 
role of homology modeling techniques that derive the 3D structure of a protein from its 
amino-acid sequence using as template the known structure of a related protein. (43) 
Results of CASP (Critical Assessment of Structure Prediction) have shown that these 
techniques have become increasingly reliable, (44, 45) with protein structures predicted 
by these methods becoming sufficiently accurate for many applications in biomedical 
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research. (46) Furthermore, it has been suggested that the landscape of known protein 
structures can also be exploited to computationally derive structural information on 
protein complexes. (47, 48) This has opened up the attractive possibility of further 
populating the structural landscape of protein complexes, which has so far remained very 
poorly characterized by experimental methods. 
Bootstrapping of structural information from known structures of individual 
proteins to complexes can be done using two main approaches. The most common 
approach, used increasingly often in CAPRI Rounds, is to predict the structures of the 
individual protein subunits by homology modeling techniques, and employ protein 
docking methods to derive the structure of the complex from the predicted subunit 
models. (49) Another approach, the so-called template-based modeling approach, (47, 50) 
models the structure of the target complex directly on the basis of a template representing 
the known 3D structure of a complex whose components are related to the subunits of the 
target protein. It was recently suggested that this latter approach could be used for 
genome-scale predictions of protein–protein interactions, provided the template 
complexes available in the PDB are sufficiently similar to the target complex. (47) 
However, due to the paucity of known structures of protein complexes, the identified 
templates are often too distantly related to the target complex to enable accurate 
modeling of its structure. This currently hampers the large-scale applicability of template-
based approaches. While the template-based approaches may ultimately represent a 
breakthrough that will play an important role in the future, almost 50% of the targets in 
CAPRI experiments are still best tackled by combining homology modeling of the 
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individual subunits with docking methods to derive the structure of the complex. But 
even this approach remains challenging, as it yields results that can vary widely in 
accuracy. An analysis of CAPRI targets has recently shown that the global sequence 
identity between the template and target proteins is a good predictor of the achievable 
quality of the docking models, (51) in turn suggesting that the ability to build accurate 
homology models for the interacting components critically influences docking 
predictions. Another study suggested that in general, the structural differences between 
the target and template proteins may affect docking performance much more than 
moderate sequence diversity, even when a template represents an independently solved 
structure of the same protein. (52) Thus, it is presently unclear how the structural 
diversity of potential templates and its relation to the intrinsic flexibility of the protein or 
to evolutionary changes may be harnessed to improve docking predictions.  
One possible solution to the above problem is simply combining the best available 
homology modeling and docking methods. However, the experience of CAPRI shows 
that this is not always the best approach. In fact, global measures of model quality such as 
the backbone root mean square deviation (RMSD) and the global distance test (GDT) do 
not properly account for localized errors that may unfavorably impact docking results. 
For example, the conformations of some side chains can be very important if they turn 
out to be in the interface, and hence their prediction may require special attention. It is 
also important to predict the accuracy of different regions in the models, as transferring 
this information to docking generally helps the selection of optimal interaction and 
tolerance parameters. While the specific requirements posed by docking do not reduce 
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the value of good homology modeling tools, they show that further integration may 
substantially improve the predicted structures of protein–protein complexes.  
A key requirement for methods developers who wish to address these questions is 
to have access to a dataset of experimentally determined target complexes, for which a 
large set of sufficiently diverse templates has been identified in the PDB for the 
components of each complex. The task at hand for developers would then be to test 
different homology modeling techniques in conjunction with various docking and 
refinement approaches, in order to determine the factors that critically influence the 
prediction performance. This is the idea underlying the benchmark dataset that we 
present in this study. Benchmark datasets play an important role in the development of 
computation methods. The protein docking benchmark, (53-57) has established a 
community-wide standard for the development and validation of docking methods. This 
benchmark contains a list of protein complexes and corresponding individual (unbound) 
components whose structures have all been solved by X-ray crystallography. By using 
the unbound structures as input, the performance of docking protocols can be assessed by 
their ability to reproduce the solved crystal structure of the complex. This benchmark 
dataset has recently been extended to include association constants and binding free 
energies curated from the literature, enabling developers to benchmark scoring schemes 
that can be used to estimate these energies from structural information. (58, 59) To 
further support method developments in the docking field, the DOCKGROUND resource 
(60, 61) proposes a reference dataset for benchmarking the performance of docking 
methods that take as input subunit models built by homology. For each of the 165 
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experimentally determined target complexes in this dataset, six models are generated for 
each of the component proteins using one state-of-art homology modeling method. (60) 
These models display model-to-native Ca RMSD values ranging from 1 to 6 Å, enabling 
methods developers to assess the impact of the accuracy of subunit models on the 
docking results.  
The dataset and resource described in this study offers the possibility of probing 
more deeply into the challenges of combining homology modeling with docking 
calculations. The dataset is built starting from complexes in version 4.0 of the Weng 
docking benchmark (54-57) that are in the enzyme inhibitor (E) and others (O) categories 
(considering the homology modeling of antibodies and antibody–antigen docking to 
represent a special challenge, (62, 63) antibody–antigen complexes are not included). 
Entries in the present dataset consist of complexes where two single chain, single domain 
components contribute to the interface. This restriction is motivated by the general modus 
operandi of the CASP experiment that models single domain proteins. Applying this 
restriction reduces the dataset to 14 enzyme inhibitor (E), and 21 others (O) type 
complexes. For each complex, a large set of curated template structures (ranging 
between !102 and 103 structures) is provided for both the receptor and the ligand protein, 
spanning a wide range in sequence similarity, and as a result, also encompassing a wide 
range in structural similarity. This dataset therefore enables to investigate how docking 
results will change when the user has the freedom of selecting not only the templates for 
the two proteins, but importantly also the homology modeling tools. The task at hand is 
hence more general than simply testing how docking performs on a predetermined set of 
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homology built models, and enables to investigate a number of additional questions, such 
as: What are the best methods for building homology models for docking? Are current 
homology modeling methods optimal if the ultimate goal is docking? If multiple 
templates are available, how to select the ones for the best docking results? How to use 
the information on model variability obtained by superimposing multiple templates? 
What are the critical issues in homology modeling that may reduce the accuracy of the 
docking solutions? Are there any side chains or loops whose conformations substantially 
impact the docked structures and hence require specific attention? Should existing 
docking methods be modified to deal with homology models, or is there a need to 
develop totally new, more closely integrated approaches?  
To facilitate such investigations, the benchmark dataset is accessible through a 
web interface that provides a range of useful features for constructing a set of homolog 
templates according to requirements set by the user. Provisions are made to frequently 
update the benchmark in synchrony with the periodic updates of the PDB, such that 
newly available templates are added to the database and obsolete entries are removed 
without human intervention. Snapshots of database versions of a given date range are also 
made available to enable comparative studies that rely on well-defined sets of structures. 
In addition, template structures can be selected based on any specified range of sequence 
similarity, thereby simulating different levels of difficulty to assess the performance of a 
docking algorithm. Templates can also be selected based on their date of release, 
enabling to simulate a realistic scenario of template availability. The possibility of 
excluding templates from the list is likewise provided to training and customizing 
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algorithms, which build homology models based on all available PDB structures. (51) 
Our benchmark dataset, and the resource for its update and customization should serve as 
a useful tool for researchers developing methods that closely integrate template-based 
modeling of individual proteins with predicting their association modes by docking 
calculations. 
 
2.2 Materials and Methods 
Building the benchmark dataset 
The starting point for building the dataset is the list of complexes from the 
widely-used docking benchmark version 4.0.18 From this list we select only complexes 
of the enzyme–inhibitor (E) or others (O) category, since homology modeling of 
antibodies and antibody–antigen docking is considered to represent a special challenge. 
To ensure that homology modeling is restricted to the level of protein domains, we 
further trim the dataset to contain only complexes representing domain–domain 
associations. The domains are defined based on the CATH classification. (64) 
For each of the complexes in the resulting list, we collect for both components of 
the complex all solved structures of related proteins deposited in the PDB. This is 
performed by running BLASTP (65) against the PDB SEQRES database using a high e 
value of 10. This lenient restriction guarantees a comprehensive coverage of the 
templates, which can then be easily filtered further to customize the benchmark for 
specific purposes. PDB entries containing a hit template for both components of the 
complex (and hence representing a homologous complex) are stored in a separate list. 
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While BLASTP is fast and convenient for the preliminary identification of related 
PDB entries, further steps are necessary to verify that the alignment does indeed cover 
the protein domain of interest, and that the solved structure contains all residues in the 
PDB SEQRES records (discrepancies between the recorded sequence in SEQRES and 
that in the solved structure are not uncommon). To this end we retrieve the amino acid 
sequence from the atomic coordinates records of each BLASTP hit, and perform a 
pairwise global alignment of this sequence with that of the corresponding component of 
the target complex. This alignment is performed using the Needleman–Wunsch algorithm 
(66) as implemented in the Needle program of the EMBOSS (67) package with the 
BLOSUM62 scoring matrix. These alignments are then used to calculate the percentage 
of sequence identity and similarity by dividing the number of identical or positive 
matches by the length of the target sequence covered by the pairwise alignment. Two 
residues are defined to be a positive match (i.e., similar) if they have a positive score in 
the BLOSUM62 matrix.  
The identified template structures are structurally aligned to the solved structure. 
The Root Mean Square Deviations (RMSDs) of the Ca atoms derived from these 
alignments, as well as the aligned templates structures are provided for each of the 
targets. These provide convenient and standardized starting structures for benchmarking 
of both homology modeling and docking algorithms. 
 
Customized, dynamic generation of template sets 
The set of templates for each of the complexes in the benchmark can be defined 
by the user, by specifying a range of sequence similarity, or sequence identity values. The 
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retrieved set can be filtered further by experimental method (X-ray, NMR, or All) or 
release date. In addition, the user can generate a list of PDB chains to be excluded from 
the template set, e.g., PDB chains with sequence similarity higher than the higher cutoff 
in the specified range (e.g., higher than 60% if a range of 30–60% sequence similarity 
was specified). This is helpful for the optimization of modeling approaches that use 
templates with very low global sequence identity.(51) The customized benchmark can be 
viewed dynamically online, or downloaded in text format. 
For each complex in the benchmark, template sets are provided for both the 
receptor and the ligand, as well as for the complex (i.e., structures of a complex formed 
by a homolog of the receptor and a homolog of the ligand), when available. The latter is 
helpful for the calibration of modeling tools aimed at refinement starting from a 
homologous interface. Thus, our benchmark allows for comparing the performance of 
modeling tools that use free or bound homolog structures, similar to earlier docking 
studies that used the bound or free monomer structures to assess the influence of binding 
on the structure of the individual partners, and the resulting effects on modeling accuracy. 
Each template list contains a detailed description of the individual template 
structures, including the PDB ID (with link both to the PDB repository for download of 
the original structure, as well as a link to the structurally aligned template). In addition, 
information is provided on the protein chain(s), the name of the protein, the method used 
for structure determination, the resolution (if solved by X-ray crystallography), % 
sequence identity and similarity, the RMSD to the target structure, and the raw output 
from the pairwise sequence alignment. The table can be sorted by clicking on the header 
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of any column. In addition to the pairwise sequence alignments between all target–
template pairs, the benchmark resource also provides a link enabling dynamic calculation 
and display of multiple sequence alignments (MSA) of the shown templates by running 
MUSCLE. (68) Prior to generating these alignments, the redundancy of the template 
sequences is reduced by removing identical sequences. 
While any arbitrary template sets can be dynamically generated using 
combinations of the above-mentioned filters, we also provide a Light Version of the 
benchmark. This version simply returns the best template structure available for each 
target (the highest resolution X-ray structure). 
 
2.3 Results and Discussion 
The benchmark dataset 
Characteristics of the full benchmark dataset of 35 single-domain complexes are 
listed in Table 2.1. Templates in this list are structures of domains with 30–60% sequence 
similarity to individual components of each complex (the default similarity range). The 
table lists the number of retrieved templates, their sequence similarity, and Ca RMSD 
values of the template versus target structures after structural superimpositions (mean and 
standard deviation values). The number of templates retrieved for individual components 
tends to be rather large, ranging from slightly below 100 to as many as 1000. 
Interestingly, while the retrieved templates display on average similar sequence similarity 
levels of 35–45%, they feature a much larger range in structural similarity with the target 
complexes (from <2 A° to >11 A ° RMSD). Analysis of the relationship between the 
  
43 
sequence similarity and the RMSD values shows a weak anti-correlation between 
sequence similarity and RMSD (Pearson correlation coefficient 5 20.57, among !62,000 
pairs of target/template with 30–70% sequence similarity). So, in general, lower RMSDs 
do correspond to templates with high sequence similarity to the targets, but the 
correlation coefficient is not strong enough to justify selection based on sequence identity 
only. The last column in Table 2.1 lists the number of structures where homologs for both 
the receptor and ligand coexist in the same PDB. All the additional information about the 
retrieved templates, the corresponding multiple sequence alignments and superimposed 
structures are available on the benchmark website (http://cluspro.bu.edu/benchmark). 
Note that all but two of the complexes in Table 2.1 have homologs that can be used for 
testing template based docking methods. We emphasize that such complexes are 
available because the benchmark set includes heavily studied complexes. In contrast, 
very few CAPRI targets had homologous complexes suitable for accurate template based 
docking, and in most cases, it was necessary to build and dock models of the component 
proteins. However, the standard docking methods frequently failed to provide accurate 
results, which contributed to the motivation for developing the benchmark described in 
this work. 
For this target complex, we identified 569 related structures for Caspase-9 (chain 
B), 555 corresponding templates for XIAP-BIR3 (chain A), and 8 related complexes 
containing both proteins (Figure 2.1). A large number of structures have been solved for 
proteins related to caspase-9. Most of these are other caspases (caspase-3,27, 28, and so 
forth) with high structural resemblance to the target, but rather low similarity in 
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sequence. While the global high similarity may make it an easy case for modeling the 
structure of caspase-9, the low conservation of the interface residues between the target 
and this selection of templates may represent a significant challenge in predicting, and 
accurately modeling, the interface of this complex. 
 
Table 2.1 Single-Domain Template Dataset Generated at 30–60% Sequence Similarity 
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An illustrative example: the complex of caspase-9 and XIAP-BIR3 (1NW9, entry 13 
in Table 2.1) 
 
 
Figure 2.1 Complex 1NW9: interaction of Caspase-9 (chain B) with XIAP-BIR3 
(chain A). A: Multiple sequence alignment of selected templates (around 30% sequence 
identity) of 1NW9_B, Caspase-9. B: Local sequence alignment of the same templates at 
the interface region of Caspase-9 and XIAP-BIR3. C: Target complex superimposed with 
each partner’s template structures. Cyan and transparent blue, Caspase-9 and its 
templates; green and transparent green, XIAP-BIR3 and templates. 
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Concluding remarks 
We built a resource aimed at facilitating the development and evaluation of 
combined homology modeling and protein–protein docking methods. The resource offers 
easy means for generating large, customized ensembles of potential template structures 
from the PDB, for the components of target complexes representing hetero-complexes of 
single domain proteins from the widely-used docking benchmark V4. Using these 
template ensembles in conjunction with the corresponding targets, methods developers 
can investigate the influence of various factors, such as sequence and structural diversity, 
on the integrated process of template-based modeling and protein docking and its 
outcome. The resource tackles only the task of generating a curated set of templates for 
each target complex of the docking benchmark, and can thus serve as a starting point for 
the development and evaluation of any combination of template-based modeling, docking 
and refinement methods. Moreover, this curated set is not static over time but is 
dynamically updated on a weekly basis by automatically retrieving additional templates 
representing newly released PDB structures and eliminating those corresponding to 
obsolete PDB entries. In addition, new complexes added to the protein docking 
benchmark by the Weng lab will be manually introduced to our resource on a regular 
basis, and complemented with the corresponding templates from the PDB. The 
benchmark dataset can be viewed online and downloaded from the web site, 
http://cluspro.org/benchmark. 
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CHAPTER THREE 
Minimal Ensembles of Side-chain Conformers for Modeling Protein-fragment 
Interaction 
3.1 Introduction 
Fragment-based drug discovery (FBDD) has rapidly grown in the last ten years. It 
is established as one of the mainstream standards in the field of small-molecule drug 
discovery, challenging other currently dominant technologies such as high-throughput 
screening (HTS). Instead of exploring the entire chemical space with drug-size 
molecules, FBDD takes a different strategy by screening with a much smaller collection 
of the fragment and is believed to be more efficient and thorough for this task.  
FBDD starts with the determination of initial highly efficient fragment binders. 
Many high-resolution experimental methods have been widely used to screen fragment 
libraries against the pharmaceutical target of interest, including X-ray, NMR, surface 
plasmon resonance (SPR), mass spectrometry, isothermal titration calorimetry (ITC), etc. 
But, all these methods suffer from the issues of being time consuming and low-
throughput, hence not efficient for a large-scale fragment screening. Computational 
screening, using docking methodologies for the fragment, works as an alternative to the 
experimental methods and helps to avoid the above issues with the running parameters 
optimally adjusted (69).  
In spite of the general agreement that fragment docking is challenging due to a 
certain of concerns including score function and search space, there are indeed a few 
good fragment docking tools with satisfactory performance for binding mode prediction. 
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Reported by Marcou group, on a data set of 42 protein-fragment complexes, FlexX, 
Glide, Gold, and Surflex can predict correct fragment binding modes 40, 70, 70 and 60% 
of the time respectively(70). Although the relative success of accurate fragment-binding 
mode prediction using docking methodologies, it is still considered challenging. Many 
concerns about docking have been discussed including, but not limited to, 1) fragment 
binding site identification and characterization; 2) scoring functions that were originally 
designed and optimized for larger drug-like molecules, not fragments. Besides all the 
above factors, the work in this chapter intends to target another key factor that affects the 
docking performance, the interfacial side chain flexibility. Proteins are dynamical rather 
than static. It is easy to observe that many side chains of a protein move among some 
conformers. Static X-ray crystallography experiment for free protein reveals multiple 
conformations for surface side chains. Upon physiological events, like molecular 
interaction, they are also subjected to either backbone or side-chain conformational 
change. It has been well supported that proteins bear multiple energetically similar states 
and fluctuate among these states rapidly voluntarily (conformation selection model(71)) 
or by force (induced-fit model(72)). Following an event like fragment binding, the 
ensemble of interface side-chain conformations undergoes a population shift, 
redistributing the states. It is thus reasonable to consider-side chain flexibility for 
improving the performance of in silico fragment docking. Edelman and coworkers 
explored the side-chain flexibility in the ligand binding interfaces by comparing the 
complexed and uncomplexed structures downloaded from the PDB database(73). They 
found that ~85% of the cases show side-chain conformational changes in three residues 
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or less and the flexibility scale is biased towards some specific side-chain types. It was 
believed that the inclusion of side-chain flexibility for a limited number of binding 
interface residues would help improve docking performance by reducing search space. 
But no work has been published to justify the point so far. In this work, we performed a 
systematic study with a set of high-affinity fragment binding cases, retrieved from a well-
curated database, PDBbind(74) (http://www.pdbbind.org.cn/, see Methods for detail). 
Firstly, the variability of the interface side-chain conformation was evaluated across all 
different residue types to characterize the profile of side-chain flexibility upon small 
fragment binding. Then we applied an in-house end-group based side-chain conformation 
ensemble generation method, EGLUM (see Methods for definition), and showed its 
performance on improving the accuracy rate of finding the bound conformation of the 
interface side chains with the few top-ranked conformations in the ensemble. Using a 
state-of-art docking tool, Autodock Vina (75), a steric clashing analysis was conducted to 
observe the clashing between the side-chain conformation in unliganded state and the 
corresponding aligned native fragment binding mode. A subset of four residue types was 
then enriched to represent the statistically most clashing ones in the result of the above 
clashing analysis. Subsequently, we tested the contribution of the subset on improving the 
fragment docking performance using Autodock Vina. Multiplicity and combination were 
further considered to maximize the improvement of docking performance without 
massively increasing computational cost. Eventually, a simple, energy score ranked 
protocol was suggested to implement accurate fragment docking in the cost-efficient 
mode. The novelty of this job includes 1) a novel, systematic and knowledge based study 
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illustrates the overall profile of side-chain flexibility upon fragment binding; 2) A 
statistical steric clashing analysis prioritize a small subset of residue types that 
contributes the most to the poor performance in unbound docking. 3)Focusing on the 
cases bearing the statistically enriched set of residue types in the interface, an ensemble 
generation method based protocol was proposed and shown to improve the docking 
performance to a satisfactory degree. 
 
3.2 Materials and Methods 
Side-chain end group definitions 
 Assuming that the backbones do not significantly change upon small fragment 
binding, the interface side-chain conformers are represented by the positions of their 
functional groups located close to the end of the side chains. Here, we used the positions 
of the end groups, shown in Table 3.1, to describe side-chain conformations and to 
measure conformational changes. Some of the end groups are defined as a middle point 
between two side-chain atoms to account for the ambiguity of placement or symmetry of 
these atoms. 
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Table 3.1 End Group Definition 
  
Side	Chain	 End	Group	
ARG	 NH1-NH2	
ASN	 OD1-ND2	
ASP	 OD1-OD2	
CYS	 SG	
GLU	 OE1-NE2	
GLN	 OE1-OE2	
HIS	 CE1-NE2	
ILE	 CD1	
LEU	 CD1-CD2	
LYS	 NZ	
MET	 CE	
PHE	 CZ	
PRO	 CG	
SER	 OG	
THR	 OG1	
TRP	 CH2	
TYR	 CZ	
VAL	 CG1-CG2	
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Methods of conformer generation 
 To generate ensembles of conformers for the interface side chains, we use a 
method called end group library with unbound conformer and minimization 
(EGLUM)(76). Starting from the end group library, we perform energy minimizations to 
reach local minima. The interface side chains are considered one-by-one in the 
minimizations, with all others being fixed in the unbound state. The energy function for 
the minimization includes the bonded and van der Waals terms of the Charmm 
potential(77), and the electrostatic/solvation term based on the analytical continuum 
electrostatics model(78). A minimization run either succeeds by ending in a local 
minimum or fails if the initial steric clashes cannot be resolved. To each minimized 
rotamer from a successful run, the probability of the corresponding initial rotamer is 
assigned. After finishing all minimizations, the resulting conformations are clustered 
based on their end-group positions. We use a clustering radius of 1 Å and a simple 
algorithm. For each end group position, we first count the number of neighbors within the 
1 Å radius. The position with the highest number of neighbors is selected as a first cluster 
center, and the structures within 1 Å (i.e., the members of the first cluster) are removed. 
Next, we again select the position with the highest number of neighbors within the 1 Å 
radius to form the second cluster. The process is repeated until the entire set is exhausted. 
For each cluster, we define a non-normalized probability by adding the probabilities of all 
cluster members. Finally, we rank the clusters according to their cumulative probabilities 
and consider the centers of the few highest-ranking clusters as predicted conformers. 
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Test set for determining the minimal ensemble of conformers 
 As illustrated in Figure 3.22, we focused on a set of 611 protein-fragment 
complexes from the PDBbind Database(74), a well-curated collection of experimentally 
measured binding affinity data for the protein-ligand complexes available in the Protein 
Data Bank (PDB). For each bound system, we retrieved an unbound structure by 
searching the PDB for all the candidate protein chains with 100% sequence identity. We 
then aligned the found protein chains to the target bound protein and identified a structure 
as unbound as long as it bears no heavy heteroatom within 5 Å range of any heavy atom 
of the aligned fragment. Moreover, a fragment binding interface is extracted from each 
unbound structure as the residues with any of their atoms falling into 5 Å range of any 
heavy atom of the aligned fragment. We further filtered the data set under the criteria of 
small fragment size (MW < 200 Da) and no obvious backbone shift upon fragment 
binding (CA RMSD < 1.5 Å). To summarize, the final data set contains 366 protein-
fragment complexes. Each of them has a corresponding unbound structure and fragment 
binding interface identified. The total number of the interface side chain is 4013. Both the 
size and side-chain type composition of the interfaces are shown in Figure 3.1.  
For interface side chains in the unbound structures, we generated the ensembles of 
side-chain conformers by EGLUM and tested these conformers for the closeness to the 
known bound conformation. The closeness was measured as a distance between the entire 
corresponding side chain after placement of the generated and bound conformers to a 
local backbone-based coordinate system, in which Ca is at the origin, the Ca-N vector 
defines the x-axis, and the y-axis is along the component of the Ca-C vector 
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perpendicular to the x-axis. The z-axis is obtained by the vector product of x and y. A 
side-chain conformer satisfies the 1 Å accuracy criterion if the distance between its side 
chain and the side chain in the bound protein structure is less than 1 Å. We present the 
average and residue type specific accuracy of our method for generating conformer 
ensembles in the Results section for 1 Å accuracy thresholds. 
 
Steric Clashing Analysis  
 We used the state-of-art small molecule docking algorithm, Autodock Vina to 
perform steric clashing analysis for all the systems in the set. For each interface side 
chain of the unbound structures in the data set, an energy value was retrieved by docking 
the fragment on one-by-one basis using Autodock vina. The raw energy scores were 
collected and subjected to plotting for both distribution and percentage of clashing 
(score > 0) across all the side chain types.  
 
Crucial residue enrichment with ANOVA 
 The clashing data was grouped by residues type and subjected to a normality test, 
to check the fulfillment of the normality assumption required by the ANOVA test. We 
used the normal probability plot, provided by the Python module “SciPy.Stats”(79, 80). 
Then, a light-weighted statistical computation Python package, “Pyvttbl” (80), was used 
to perform one-way ANOVA test. Finally, a variance inhomogeneity robust, non-
parametric Post-Hoc test, Games-Howell(81), was applied to enrich the residue type 
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pairs, representing the most significant difference of steric clashing at a certain level of 
significance. 
 
Autodock Vina docking 
To understand how the side chain flexibility affects the docking performance, we 
set up Autodock Vina runs to dock fragments locally to binding site regions, defined as a 
grid box centered by the geometric center of the aligned fragment with the side of 10 Å. 
For each case, both protein and ligand were prepared and transformed into the PDBQT 
format using MGLTools. In addition to the Autodock Vina run in the above-mentioned 
default mode, we also ran the local dockings by allowing flexibility for either single side 
chain or entire interface (multiple side chains). Both are implemented as running 
parameters in Autodock Vina. For the latter, the box is adjusted to accommodate the 
entire site by making it large enough to cover the farthest atom of the interface residues 
with an additional padding (0.2 Å).  
 
Side-chain replacement 
 Under some scenarios where an original side-chain conformer needs to be 
replaced by an ensemble conformer, we replaced in the PDB file, all the original atom 
coordinates of the side chain with the coordinates of the ensemble conformer after careful 
alignment.  
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Ligand efficiency 
 Ligand efficiency (LE) is a measurement of the binding energy per atom of a 
binding ligand. Using the binding affinity values recorded, we calculate LE by its 
definition, LE = (DG)/N = 1.4*pKd/N. 
 
RMSD calculation 
 We used Openbabel (82)to read molecules in different file formats and a Python 
package ‘NetworkX’(83) to construct a network graph to represent molecules by 
iteratively denoting atoms as nodes and bonds as edges. A local Graph Matcher algorithm 
was used to extract the isomorphic subgraph between two graphs (molecules). Hence, 
RMSD is calculated by its definition as the root-mean-square deviation of all atomic 
positions between a pair of matching side chains. 
 
3.3 Results and Discussion 
Ligand efficiency distribution of the data set 
 First of all, to retain an initial sense of the quality of the fragment binding systems 
from the PDBbind database, the ligand efficiency was calculated and displayed in the 
histogram in Figure 3.3. As shown, the final data set consists of fragment binding 
systems with good ligand efficiency, ranging from 0.2 to 1.6 Kcal/mol per heavy atom. 
We intended to use this data set in our study.  
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Comparison of docking performance on structures in Unbound v.s. Bound states 
 A study has been performed (84) showing that fragment docking on liganded 
structures generates a higher level of accuracy than on unliganed structures. To 
understand this discrepancy of docking performance in our data set, we simply used 
Autodock Vina, a state-of-art small molecule docking tool, to perform fragment docking 
on all the 366 target systems, using protein structures in either the unbound or bound 
state. The RMSD distances between predicted fragment poses and corresponding 
superimposed native fragment poses were collected. We then defined a term “success 
rate” as the percentage of all the systems in the dataset that have at least one of the top 
five ranking pose predictions less than 2 Å away from the corresponding native pose in 
RMSD. We compared the “success rate” between unbound and bound docking. As shown 
in Figure 3.1, out of the 366 systems in total, the “success rate” of Autodock Vina 
docking using bound structure is 62.8%, while the counterpart for docking using 
unliganded structures is 33.6%. We did the same to a subset of structures bearing at least 
one of the four residue types with the most clashes (ARG, LYS, GLU and GLN). The 
data in the Figure 3.20 shows that the “success rate” of Autodock Vina docking using 
bound structures is 64.6%, while the counterpart for docking using unliganded structures 
is 32.0%. The performance gap for the subset is a little larger than for the entire set, 
because of the nature of the flexibility of the four residue types. In either case, such a 
large difference (~30%) convinced us of the necessity of this study on optimizing the 
fragment docking by adjusting the side chain flexibility in the fragment-binding 
interfaces.  
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Figure 3.1 Success rate of AutoDock Vina docking using proteins in either unbound 
or bound state. Success is defined as the percentage of the entire dataset that has 
‘successful’ prediction with one of the top 5 ranking pose predictions less than 2 Å away 
from the corresponding native pose. The blue represents the success rate of unbound 
docking (33.6%), and the green represents the success rate of bound docking (62.8%). 
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Summary Statistics of Binding Sites 
For all fragment binding interfaces in the data set (see Materials and Methods), 
plot A (left) in Figure 3.2 shows the distribution of the number of movable side chains in 
the interfaces. Most of the interfaces contain a variable number of movable side chains (0 
- 20). A few bearing a large number of movable side chains can be explained because 
multiple copies of the fragment simultaneously bind to different surface regions. To 
determine if different side chain types are universally distributed in the binding 
interfaces, the plot B (right) in Figure 3.2 shows the side-chain type specific frequency in 
the interfaces. Obviously, the frequency is not universally distributed across different side 
chain types. The most abundant ones include histidine, aspartic acid, leucine, tyrosine, 
while the least abundant ones are methionine, cysteine, proline, lysine. These plots give a 
general picture of the composition of the fragment binding interfaces in our data set. 
Composition does not necessarily contribute to the docking performance, which is the 
key topic of our study and will be discussed in the subsequent sections. 
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      A      B 
Figure 3.2 Summary of movable interface side chain. A) The distribution of the 
number of movable interface side chain. B) The frequency of movable interface side 
chains by residue type. 
 
  
61 
 
Figure 3.3   Distribution of ligand efficiency. The histogram displays the distribution of 
ligand efficiency of all the fragment binding cases in the data set. It ranges from 0.2 to 
1.6 Kcal/mol per heavy atom.  
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Bound conformation in the ensemble of unbound states 
 For each interface side chain in the dataset, we generated an ensemble set of side-
chain conformers using our end group-based ensemble generation method, EGLUM. The 
RMSD distance was calculated between the minimal ensemble conformers and the 
superimposed side-chain conformer in the bound state. We intended to illustrate how well 
the small ensemble of side-chain conformers can find the side-chain conformer in the 
bound state under different RMSD thresholds. We call it a success if either the unbound 
conformer or one of the ensemble poses is less than a certain distance (e.g. 1.0 Å) away 
from the side-chain conformer in the bound state. Eventually, we can calculate a success 
rate as the percentage of the side chains in the data set that can successfully find the 
bound conformer with a various number of ensemble conformers, with diverse RMSD 
thresholds. As shown in Figure 3.4, the success rate of finding bound conformers is 
gradually increased by including more top-ranking minimal ensemble poses. For 
instance, with a RMSD threshold of 1.0 Å (green), the success rate increases from 89.2% 
to 92.6%. Although the gains of success rate look small, it should be kept in mind that the 
success rate is averaged among all side chain types (both flexible and inflexible). The 
contribution to the success rate gain is not universally attributed to the different side 
chain types, as we will discuss in more detail subsequently.  
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Figure 3.4 Success rate of finding the bound conformation with different accuracy 
in small ensembles of side-chain conformers. For each side chain in the data set, 
RMSD distances between unbound/ensemble conformers and bound conformer are 
calculated. Success rates are summarized as the percentage of the side chains in the data 
set that can successfully find the bound conformer with either unbound or a various 
number of top-ranking ensemble conformers, with diverse RMSD thresholds. RMSD 
threshold is color-coded: 0.5 Å (blue), 1.0 Å (green) and 2.0 Å (red). The five groups 
from left to right are as follows: Unbound only; Unbound plus top one conformers; 
Unbound plus top two conformers; Unbound plus top three conformers; and Unbound 
plus top four conformers.  
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Prediction of bound conformers for different side chain types 
 Above, we described the small gain in the success rate of finding bound 
conformers by including more ensemble conformers generated by our approach, 
EGLUM. To further understand how different side-chain types, contribute to the success 
rate of finding the bound conformer, we calculated the success rate of finding bound 
conformers, but in a side-chain types specific manner. Figure 3.5 shows the success rate 
of finding bound conformer with a 1 Å threshold for each of the 18 residue types, using 
the small ensembles including both unbound and up to four minimal ensemble 
conformers. As shown, the success rate of finding the bound conformers by original 
unbound conformers (Cyan star) ranges from 67.8% (Gln) to 98.5% (Val) across all 
residue types. It delineates a certain amount of mismatching the success rate of finding 
the bound conformer by merely unbound conformer (Cyan star) ranges from 67.8% (Gln) 
to 98.5% (Val). And, the success rate is obviously increased with the inclusion of 
ensemble conformers for all side chain types, except Val, Trp and Pro. Also, some side 
chain types (e.g. Val, Trp, Ser) have an ultimately higher accuracy of finding bound 
conformer than others (e.g. Tyr, Pro, Arg). All these findings provide a good basis for the 
subsequent analysis of docking performance improvement by side-chain conformation 
perturbation. 
Similarly, the success rate of finding the “unbound” conformation was also 
summarized, by calculating the RMSD distance to unbound conformers instead. Figure 
3.6 shows the success rate of finding unbound conformers with 1 Å accuracy for each of 
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the 18 residue types with small ensembles including up to four minimal ensemble 
conformers. As shown, the success rate of finding the unbound conformer is much lower 
than that for finding bound conformers for many side chain types, except for Ile, Leu, 
Val, Pro, etc. We concluded that our end group-based ensemble generation method 
generated local minima ensembles for side-chain conformers, driving them more towards 
the bound rather than the unbound state.  
Moreover, in a more straightforward way, Figure 3.7 presents the “success” of the 
side-chain conformer ensemble set in finding the conformation in a bound state in terms 
of the RMSD distance. For each side chain, we calculated the RMSD distance of the 
unbound conformer away from the bound conformer. Then we did the same to calculate 
all RMSD distances of the top four highest ranking rotamers in the ensemble set away 
from those of the bound conformer. We determined the minimum RMSD distance from 
the set mentioned above, then plotted the minimum RMSD distance against the RMSD 
distance between the unbound conformer and bound conformer. In Figure 3.7, the points 
on the diagonal (red line) represent the side chain cases for which the unbound conformer 
is already closest to the bound conformer. No further gain in finding bound conformer is 
achieved through the use of a small ensemble set. However, all the points above the 
diagonal represent the side chain cases where a small ensemble set helps to find a 
conformer closer to the bound conformer. To summarize, 21.0% (842/4013) side chains 
in the entire data set fall into the “above-diagonal” category. Out of the 842 side chains, 
469 (55.7%) have top-ranking minimal ensemble rotamer closest to the bound conformer, 
while the numbers for the second, third, and fourth highest ranking are respectively 218 
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(25.9%), 122 (14.5%) and 33 (3.9%). The fact that over 80% of the improvement in 
finding the bound conformer can be efficiently achieved by merely considering as low as 
two top-ranking minimal ensemble rotamers indicates the feasibility of designing a 
protocol for improving docking performance with fairly a small number of ensemble 
conformers.  
 
 
Figure 3.5 Success rate of finding the bound conformation with 1 Å accuracy in 
small ensembles of side-chain conformers. Results are shown for each side chain type 
separately, averaged over all the protein complexes in the data set. Cyan stars, green 
circles, red vertice-up triangles, yellow vertice-down triangles and purple diamond, 
respectively represent the accuracy for ensemble with unbound conformer only, unbound 
conformer plus top one, two, three, and four conformers.  
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Figure 3.6 Success rate of finding the unbound conformation with 1 Å accuracy in 
small ensembles of side-chain conformers. Results are shown for each side chain type 
separately, averaged over all the protein complexes in the test set. Cyan stars, green 
circles, red vertice-up triangles and yellow vertice-down triangles, respectively represent 
the accuracy for ensemble with top one, two, three and four conformers.  
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Figure 3.7 Comparison of RMSD distance to bound conformation. RMSD distance to 
the bound conformation is compared between the unbound conformation and the closest 
one in the ensemble set, including both the unbound conformer and top four ranking 
minimal poses. The points which fall on the red diagonal line represent the side chains 
where the unbound conformer is closest to the corresponding bound conformer among 
the ensemble set. The points above the red line represent the side chains where at least 
one conformer in the ensemble set is closer to the unbound conformer. 
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Clashing distribution upon fragment binding 
Energetically favorable fragment binding poses are usually not sterically clashing 
with the interface side-chain conformers in the bound state. But, due to the discrepancy of 
interface side-chain conformer between unbound and bound state, it might not be the case 
for the interface side-chain conformers in the unbound state. Steric hindrance could be 
the primary culprit for the low performance of docking using the rigid body unbound 
structure. In this section, we intend to gain insight into the profile of steric clashing 
between the unbound interface side-chain conformers and the native fragment binding 
poses in our data set.  
For each interface side chain in the unliganded structure, we use the Autodock 
Vina to calculate the energy score between single interface side chain and aligned 
binding fragment in a one-by-one mode. We declare an event of “clashing” as an energy 
score greater than zero. All the energy score values are collected and summarized to 
calculate the percentage of steric clashing across all side chain types. The red bars in 
Figure 3.8 show that three residue types in the unliganded structures (Gln, Arg, Lys) most 
frequently (>33%) clash with the aligned binding fragments. This means at least two 
things: 1) all the three types of side chains are long and possess high degrees of freedom 
in terms of the number of rotamers; 2) their conformations in the unbound structures are 
quite different from the ones in the bound structures and are not energetically favorable 
for the native fragment binding poses. A rigid body computational docking using 
unliganded structures with these side chain types highly possibly produces an inaccurate 
result because of the steric hindrance. The second highest frequently clashing residues 
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include Met, Glu and Tyr, with the percentage ranging from 18% to 21%. The blue bars 
in Figure 3.8 represent the abundances of all the residue types in the interface. As shown, 
the three most frequently clashing residue types are not the most abundant ones in the 
interface. This excludes the possibility that the high percentages of clashing are merely 
related to the high abundance in the small fragment binding interfaces. For a more 
straightforward view of clashing by side chain type, Figure 3.9 shows the clashing by 
plotting raw energy scores across the different side chain types. As shown, a large 
amount of steric clashing (score > 0) exist between the unbound side chains and the 
fragments. Extreme energy scores appear for a few residue types such as Gln and Tyr. 
Given the average sizes of the interfaces and the distribution of steric clashing across 
diverse residue types, a small subset of residue types needs to be statistically enriched to 
represent the largest fraction of clashing. Hence, an improvement in the maximum 
docking performance could be gained by adjusting side-chain conformations of this 
subset. We will discuss in more detail in the next section.  
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Figure 3.8 Steric clashing percentages and interfacial abundances across all the 
residue types. The percentage of steric clashing (score > 0) between native fragment 
poses and unbound side-chain conformers is plotted across all residue types in red bars 
(left Y-axis). Moreover, the abundances of all the residue types in the interface are 
plotted in blue bars (right Y-axis). 
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Figure 3.9 Distribution of steric clashing by side chain type. The Autodock Vina 
energy score between native fragment pose and unbound side-chain conformer is 
calculated and plotted across all side chain types. As shown, while almost all the side 
chain types have a certain level of steric clashing (score > 0), some types, such as Tyr, 
Gln, Phe, show severe clashing with high energy scores.   
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Enrichment of side chain subset bearing the most clashing 
As discussed in the previous sections, the steric clashing happens to a variety of 
side chain types in the fragment binding interface site. For the best performance of 
docking prediction, it is very costly to simultaneously adjust the side chain of all interface 
residues, even though our ensemble generation method, EGLUM can efficiently find the 
‘correct’ bound conformation. Hence, we intend to enrich a subset of all the side chain 
types whose side chain perturbations provide the satisfactory gain of docking 
performance. A simple one-way analysis of variance (ANOVA) test is performed to 
observe, 1) whether or not the steric clashing is universally distributed across all side 
chain types; 2) whether or not a side chain type clash significantly higher over another 
side chain type. As we know, the ANOVA test needs to satisfy three assumptions, 
including 1) independence of observation; 2) normality; 3) homogeneity of variances. 
First of all, we can assume that all interface side-chain conformers in the unliganded 
structure clash with the binding fragment independently, because the unliganded structure 
was determined under the condition without the presence of the fragment at all. Secondly, 
a normal probability plot is drawn for each side chain type to assess whether or not the 
clashing data set of a specific side chain type is approximately normally distributed. As 
shown in the Figure 3.10, there are 18 subplots in total, each representing a normal 
probability plot for one side-chain type. In each plot, a straight line in red is fit to the 
points as a reference line. The further the points vary from this line, the greater the 
departure from normality is. As we expect, for most of the side-chain types, the majority 
of the data points are located close to the red reference line, except some side-types 
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displaying certain levels of departure, primarily due to a few extremely clashing 
incidents. Thirdly, the variance of clashing is not homogeneously distributed among all 
the side chain types from the “descriptive statistics table” in Table 3.2. But, ANOVA is 
robust to the heterogeneity of variance. 
The ANOVA result in Table 3.2 shows that the steric clashing is significantly 
unequally distributed across all the side-chain types, with a p-value of the F test as low as 
1.03e-16. Due to the inhomogeneity of variance, we applied a non-parametric posthoc 
pairwise comparison test, Game-Howell test, to determine the pairs of side chain types 
whose clashing differences are statistically significant. As shown in Figure 3.11, under a 
loose enough p-value cutoff, 0.1, there exist 15 pairs of side chain type that bear 
significant pairwise difference of clashing. The more clashing group includes only four 
side chain types, Arg, Lys, Glu and Gln. Three (Gln, Arg, Lys) of four side chain types 
belong to the most abundantly clashing ones described in the previous section with the 
other one (Glu) in the second tier. Finally, the evidence points to the selection of the 
subset of the four side chain types for subsequent docking performance studies, given that 
they appear in the top tiers in terms of both abundance and degree of clashing. 
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Figure 3.10 Normality test. To observe the reliability of the normality assumption of the 
ANOVA test, a probability plot is drawn against energy scores for all 18 side chain types. 
The red line represents the reference line. The further the points deviate from the line, the 
less normal the data. The energy scores of all side-chain types roughly conform to a 
normal distribution with some extreme values.   
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      Descriptives 
 
 
 
 
 
 
 
 
 
 
 
    ANOVA 
 Sum of Squares df 
Mean 
Square F Sig. 
Between 
Groups 
 
1686.999 17 99.235 6.89 1.03E-16 
Within 
Groups 
 
57520.806 3994 14.402   
Total 59207.806 4011    
Table 3.2 ANOVA test of steric clashing. ANOVA test is performed to observe if steric 
clashing equally happens across all 18 side-chain types. The table “Descriptive” records 
the summary statistics of steric clashing by side-chain types, including the metrics like 
sample size, sum, mean and variance. The result of ANOVA test is shown in the table 
“ANOVA”. It can be declared that the clashing is significantly not evenly distributed 
among the side chain types with the P-value as low as 1.03e-16. 
Groups N Sum Mean Variance 
ARG 171 18.168 0.106 0.455 
ASN 236 37.323 0.158 3.896 
ASP 319 -25.864 -0.081 0.819 
CYS 110 -12.508 -0.114 0.388 
GLU 268 44.487 0.166 1.623 
GLN 127 380.144 2.993 111.12 
HIS 425 -63.187 -0.149 0.241 
ILE 162 -22.264 -0.137 0.126 
LEU 326 -39.511 -0.121 0.575 
LYS 110 9.803 0.089 0.305 
MET 108 1.601 0.015 0.888 
PHE 258 85.225 0.33 17.246 
PRO 121 -11.496 -0.095 0.231 
SER 275 -10.927 -0.04 0.472 
THR 192 6.701 0.035 0.841 
TRP 238 10.149 0.043 22.705 
TYR 288 426.644 1.481 108.558 
VAL 278 -42.104 -0.151 0.239 
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Figure 3.11 Non-parametric Post-hoc analysis. Games-Howell nonparametric posthoc 
test is performed to retrieve the side chain pairs that for which clashing score are most 
significantly different from each other. At a loose significance level - 0.1, the subset of 
Arg, Lys, Glu and Gln appears as the side-chain types with most clashing compared to 
the subset of His, Val, Ile, Leu and Cys.  
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Contribution to docking performance 
 Previously, we presented that our end group-based ensemble generation method, 
EGLUM, succeeds in finding side-chain conformers in the bound state more or less for 
diverse types of the side chains. Given the large performance gap between unbound and 
bound docking (~29%) as shown in the previous section, we are convinced of the 
necessity of testing the potential contribution of the side-chain ensemble set to better 
docking performance. We focused on a subset of four most clashing side chain types 
(Arg, Lys, Glu and Gln) as previously discussed and tried to evaluate the extent to which 
a small ensemble set of side-chain conformer can contribute to better docking 
performance in terms of success rate of finding native fragment poses within the top five 
pose predictions from Autodock Vina docking. It is worthy of mention that the interfaces 
in the dataset might contain none, one or multiple side chains of these four types. To 
evaluate the contribution of the four side chain types, we purposely selected all the 
systems containing at least one of the four side chain types in the interface. There are 147 
systems in total.  
 As shown in Figure 3.12, docking performance was compared under six different 
scenarios, including 1) Autodock Vina docking on the unliganded structure; 2) Autodock 
Vina (allowing single side chain flexibility) docking on the unliganded structure; 3) 
Autodock vina (allowing entire interface side chain flexibility) docking on the unliganded 
structure; 4) Autodock Vina docking on the unliganded structure and the structure after 
one side chain replacement with the top-ranking ensemble conformer; 5) Autodock Vina 
docking on the unliganded structure and the structure after one side chain replacement 
  
79 
with any of the top two ranking ensemble conformers; 6) Autodock Vina docking on the 
unliganded structure and the structure after one side chain replacement with any of the 
top three ranking ensemble conformers. For the scenarios 4, 5 and 6, we performed 
docking separately on both original unliganded structure and structures with one side 
chain replaced as defined. Top five ranking pose predictions by energy from each 
docking were pooled and sorted by energy again. The top five ranking pose predictions 
by energy from the pooled set form a final set of docking result (See Figure 3.19). Under 
each scenario, we call the docking prediction for a system, a “success” if any of the top 5 
ranking pose predictions is less than 2 Å away from the superimposed native fragment 
pose in RMSD. A success rate will be summarized as the percentage of success out of all 
the 147 systems under each specific scenario. As shown, the binding poses of 32.0% 
systems can be successfully predicted using the original unliganded structures with the 
default parameter setting (Scenario 1, blue). By allowing side chain flexibility in the level 
of either single side chain (Scenario 2, green) or entire interface (Scenario 3, red), the 
success rate changes to 34.0% or 23.8% respectively. It denotes that docking 
performance does not increase significantly by simply allowing side chain flexibility in 
Autodock Vina, but rather drops sharply with the inappropriate setting (e.g., entire 
interface flexibility). Nevertheless notably, the success rate rises to 40.8% by merely 
taking top-ranking minimal ensemble conformer into account (Scenario 4, purple). Also, 
the rate increases to 43.5% and 44.2% by considering the top two (Scenario 5, Brown) 
and three (Scenario 6, Cyan) ranking minimal ensemble conformers. The success rate 
will eventually reach a plateau with the inclusion of more and more ensemble 
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conformers, making it unnecessary to try. We then conclude that the small ensemble set 
of side-chain conformers generated by EGLUM does its work to improve the 
performance of Autodock Vina docking with the inclusion of top-ranking ensemble 
conformers.  
 Additionally, to view the docking performance more straightforwardly, we plotted 
directly with the calculated RMSD distances between superimposed native fragment pose 
and top pose predictions by Autodock Vina docking. Given the fact that the top-ranking 
minimal ensemble conformer contributes the most to the docking performance in terms of 
success rate (as shown in Figure 3.12), we present a boxplot to display and compare 
RMSD distributions for the top five ranking pose predictions by the Autodock Vina 
dockings on both the original unliganded structures and structures with one side chain 
replaced by the top-ranking minimal ensemble conformer. As shown in Figure 3.13, two 
subplots represent the comparison mentioned above, but for two different sets of side-
chain type respectively. The left is for the chosen clashing set of Arg, Lys, Glu and Gln, 
including 147 systems in total. The right is for the set of other long side chain types, Met, 
His, Leu and Ile, including 109 systems in total. As shown, for the set of Arg, Lys, Glu 
and Gln (left), the top five pose predictions from the dockings on structures with single 
side chains replaced by top-ranking minimal ensemble conformers (green) have a RMSD 
distribution relatively lower than that from the dockings on the original unliganded 
structures (blue). Although a few higher RMSD values do appear after the ensemble 
conformer replacement, the side chain replacement does pull the RMSD distribution 
down with the median value greatly decreased. On the other hand, the subplot for the set 
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of Met, His, Leu and Ile (right) shows no difference. This not only legitimizes our 
approach of side chain type enrichment but also justifies its contribution to better docking 
performance.  
Finally, we focused on the dockings under the scenarios 1, 2 and 4 for all the 
systems bearing any of the side-chain types Arg, Lys, Glu and Gln in the interface and 
overlaid RMSD values of best prediction from dockings under these scenarios in a 
scatterplot. We drew two plots: one to compare the top-ranking pose prediction (Figure 
3.14) and the other to compare the best in top five ranking pose predictions (Figure 3.15). 
Figure 3.14 shows the 36 “successful” docking runs on unliganded structures with one 
side chain replaced by the top-ranking minimal ensemble conformer, where the top-
ranking pose prediction is less than 2 Å away from the corresponding native fragment 
pose. Similarly, Figure 3.15 shows 62 “successful” docking runs on unliganded structures 
with one side chain replaced by the top-ranking minimal ensemble conformer, where the 
best out of the top five ranking pose predictions is less than 2 Å away from the 
corresponding native fragment pose. Both scatter plots demonstrate the diminishing 
RMSDs from docking with original unliganded structures (red and blue) to docking with 
side chain replacement (green).  
 
Visualization 
 To gain a three dimensional visualization, we chose two systems as examples and 
superimposed all the objects using a molecular graphics tool (pymol) including 1) the 
unliganded structure; 2) the aligned top-ranking ensemble conformer as a replacement; 3) 
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the top-ranking pose from the Autodock Vina runs with and without side-chain 
replacement (Figure 3.16). The side-chain conformers under consideration are shown in 
stick, as well as both the native and top-ranking pose by Autodock Vina. For example, for 
the case of alpha-N-acetylgalactosaminidase in human (top half), the graph on the left 
represents the docking result using the unliganded structure, while the graph on the right 
represents the docking result using the unliganded structure with the original side chain 
of Lys154 (magenta) replaced with the top-ranking ensemble conformer (cyan). The top-
ranking prediction (yellow) in the left graph differs from the native fragment pose (cyan) 
with 4.17 Å in RMSD. But, the RMSD for the right graph drops to 0.67 Å. Another case 
(bottom half) is for the trypsin in Bos taurus. Similarly, the graph on the left represents 
the docking result using the unliganded structure, while the graph on the right represents 
the docking result using the unliganded structure with the original side chain of Gln192 
(magenta) replaced with the top-ranking ensemble conformer (yellow). The top-ranking 
prediction (yellow) in the left graph differs from the native fragment pose (cyan) with 
3.95 Å in RMSD. But, the RMSD for the right graph drops to 0.30 Å. In both cases, steric 
clashing exists between the original side-chain conformer and the native fragment pose 
(cyan), with 1.35 kcal/mol and 2.67 kcal/mol respectively for the cases of alpha-N-acetyl 
galactosaminidase in human and the trypsin in Bos taurus. It is the steric clashing that 
forces the predictions away from the native pose. This is the reason why single side chain 
replacement alone can sharply increases the accuracy of the top-ranking prediction in the 
two cases mentioned above as well as many others.   
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Figure 3.12 Improvement of Docking performance by side-chain replacement. We 
use Autodock Vina to compare local fragment docking performance under the following 
scenarios: 1) Autodock Vina + Unbound (blue); 2) Autodock Vina (allowing flexibility 
of one side chain) + Unbound (green); 3) Autodock Vina (allowing entire site flexibility) 
+ Unbound (red); 4) Autodock Vina + Unbound with/without one side chain replaced by 
the top ranking minimal rotamers (purple); 5) Autodock Vina + Unbound with/without 
one side chain replaced by any of the top two ranking minimal ensemble conformers 
(brown); 6) Autodock Vina + Unbound with/without one side chain replaced by any of 
the top three ranking minimal ensemble conformers (cyan). Only side chain types of Arg, 
Lys, Glu or Gln are considered for 4), 5) and 6). A small improvement in performance 
(2%) is observed by allowing single side-chain flexibility in Autodock Vina, while the 
performance sharply drops 8% by allowing flexibility of the entire interface. 
Consideration of the top 1, 2 and 3 ranking minimal ensemble conformers of the types 
Arg, Lys, Glu, Gln drives the performance up by 8.8%, 11.5% and 12.2%, respectively.  
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Figure 3.13 Improvement of docking performance in RMSD. All top five ranking 
pose predictions from Autodock Vina dockings on either original unbound structures 
(Original, blue) or structures with one side chain replaced by the top-ranking minimal 
rotamer (Subcluster.001, green) were subjected to RMSD calculation with the 
corresponding superimposed native fragment binding pose. (left) All systems containing 
side chain types of Gln, Glu, Lys and Arg in the interface. (right) All systems containing 
side chain types of Ile, Leu, His and Met in the interface.  
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Figure 3.14 Improvement of docking performance by side chain replacement 
(RMSD). We compared the docking performances in RMSD among the following 
groups, using the top-ranking pose predictions: 1) Autodock Vina + Unbound (red); 2) 
Autodock Vina (allowing flexibility of one side chain) + Unbound (blue); 3) Autodock 
Vina + Unbound with one side chain replaced by the top ranking minimal rotamer 
(green). Only the side chain types of Arg, Lys, Glu or Gln are considered.  
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Figure 3.15 Improvement of docking performance in RMSD - II. We compared the 
docking performances in terms of RMSD among the following groups, using the best of 
top five pose predictions: 1) Autodock Vina + Unbound (red); 2) Autodock Vina 
(allowing flexibility of one side chain) + Unbound (blue); 3) Autodock Vina + Unbound 
with one side chain replaced by the top ranking minimal rotamers (green). Only the side 
chain types of Arg, Lys, Glu or Gln are considered. 
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Figure 3.16 Visualization of docking performance improvement. The best Autodock 
Vina prediction is superimposed with the native binding pose together with side-chain 
conformation before and after replacement with the top-ranking minimal ensemble 
conformer. The upper half shows the case of human alpha-N-acetylgalactosaminidase. 
The lower half shows the case of Bos taurus trypsin. For both cases, the native fragment 
pose is shown as the sticks in cyan. The best-predicted pose from Autodock Vina is 
superimposed. Both original and top ranking minimal side-chain conformers are shown in 
stick respectively.  
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Possibility for further improvement (combination and multiplicity)  
 Above, we discussed the successes of both finding bound conformations with our 
method (EGLUM) and improving docking performance by side-chain replacement (Arg, 
Lys, Glu, Gln). A single interface side-chain replacement by the top-ranking ensemble 
conformer improves docking performance by 8.8% (Figure 3.12) in terms of system 
number. Subsequently, we intend to investigate whether or not further improvement 
could be achieved by including either combination (multiple clashing side chains) or 
multiplicity (multiple top ranking ensemble conformers).  
First of all, we evaluated the feasibility of “combination”. As shown in Figure 
3.17, under the energy score cutoff of 1.0 kcal/mol (top), only 28 (7.7%) of the 366 
systems bear multiple clashing side chains in the interface. The number of systems drops 
to 13 (3.6%) with the energy score cutoff of 1.5 kcal/mol (bottom). By visualizing the 
situation of clashing and its relationship to the actual energy score, we estimate that 1.5 
kcal/mol is the more reasonable cutoff for true clashing. These values are calculated for 
the entire data set and could be much lower for the subset containing Arg, Lys, Glu, Gln. 
This makes the investigation on “combination” impossible due to the lack of data.  
On the other hand, to evaluate the necessity and feasibility of “multiplicity”, we 
were trying to assess if enrichment of ‘close-to-bound’ side-chain conformers can be 
achieved by the inclusion of multiple minimal ensemble conformers with different ranks. 
Is it true that higher ranking ensemble conformers resemble the side-chain conformer in 
the bound state more than lower ones? What is the adequate number of ranks to consider 
before the contribution to finding bound conformer becomes saturated? To answer these 
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questions, we simply summarize the situation of ‘finding bound state’ in terms of the 
absolute number of ‘close-to-bound’ side chain in the entire data set without or with the 
replacement of ensemble conformers of different ranks. As shown in Figure 3.18, the plot 
on the left shows that there are 2970 (74.0%) side chains out of 4013 total side chains in 
the data set that already have original unbound conformers less than 1.0 Å away from the 
corresponding bound ones. Moreover, the plot on the right shows that the inclusion of the 
top 1st, 2nd, 3rd or 4th ranking ensemble conformers adds 379 (12.8%), 192 (6.5%), 98 
(3.3%) and 22 (0.7%) more ‘close-to-bound’ conformers respectively. What we learn 
from the above summary includes: 1) more ‘close-to-bound’ conformers can definitely be 
found by the inclusion of ensemble conformers of different rank; 2) the higher the rank, 
the greater the number of additional ‘close-to-bound’ conformers are found; 3) the 
contribution to ‘finding bound’ dramatically drops to c.a. zero with a ranking equal to or 
above 4. The inclusion of the top two ranking ensemble conformers represents 83% 
(19.3%/23.3%) of the overall gain of finding bound conformers. The gain rapidly 
approaches a maximum with the inclusion of more and more lower rank minimal 
rotamers. Thus, we considered only the top two highest ranking ensemble conformers to 
test how the multiplicity contributes to the docking performance.  
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Figure 3.17 Number of systems containing varying amount of clashing side chain in 
the interface. Under the energy cutoff of either 1.0 kcal/mol (left) or 1.5 kcal/mol (right), 
a bar plot was drawn to show the number of systems containing varying amount of 
clashing (>cutoff) side chain in the interface.  
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Figure 3.18 Increase in bound conformers with inclusion of top-ranking ensemble 
conformers. (left) Stacked bar plot to show the number of both all side chains (yellow) 
and the ‘close-to-bound’ side chains (green) in the dataset, with RMSD cutoff of 1.0 Å. 
(right) Bar plot to show the number of additional ‘close-to-bound’ side chains found by 
replacement with an ensemble conformer of different rank, with RMSD cutoff of 1.0 Å.  
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 3.4 Conclusions     
Overall, we observed that the interface side-chain conformers are not as rigid 
upon fragment binding as assumed in the application of many docking algorithms. Some 
residues show more side-chain flexibility than others as shown by comparing the 
conformations in between unbound and bound state. In this study, we designed an end-
group based side-chain conformer ensemble generation method and evaluated its 
potential to reduce the conformation gap between bound and unbound states with merely 
the top-ranking ensemble conformers. A steric clashing analysis using Autodock Vina 
was then performed to characterize the clashing profile between the unbound side-chain 
conformation and the well-aligned native fragment binding pose. This allows the 
statistical enrichment of a side-chain subset that clashes the most. For all systems bearing 
this statistically-enriched side-chain subset in the interface, the docking performance was 
demonstrated to improve by replacing the original unbound side-chain conformation with 
one of the top-ranking ensemble side-chain conformers, in terms of both success rate and 
RMSD. The improvement was not observed for another random set of the residues with 
long side-chain. The ultimate goal of this study is to propose a simple, practical and cost-
efficient protocol to enhance docking performance with a small ensemble of side-chain 
conformers. As shown in the results, the docking performance improves with the 
replacement of top-ranking ensemble conformers. The improvement increases with the 
inclusion of more top-ranking ensemble conformers (termed multiplicity) until a 
maximum enhancement is reached. To implement the ‘multiplicity’, a metric is needed to 
filter solutions from multiple docking runs objectively. The docking energy score was 
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used for this role in a proposed protocol shown in Figure 3.19. In this protocol, three 
docking runs are performed separately, using either the original unbounded structure or 
the structure with single side chain replaced by either of the top two ranking conformers 
of the most clashing residue (Arg, Lys, Gln or Glu). The top five ranking solutions by 
energy score from each of the three docking runs are pooled and re-sorted by energy 
score. Eventually, success is determined using a final set of top five energy-favourable 
solutions in which has one solution is close (< 2.0 Å in RMSD) to the aligned native 
pose. The performance of the protocol is shown in Figure 3.12. Our protocol outperforms 
the original Autodock Vina protocol with either individual or entire interface side-chain 
flexibility by up to 20.4% before the performance reaches a plateau. Moreover, the time 
efficiency renders the protocol feasible since three parallel local dockings with Autodock 
Vina can be completed in a relatively short period of time. We hope that our in-house 
ensemble generation method (EGLUM) based method can be utilized by fragment 
binding algorithm developers to maximize the prediction performance. 
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Figure 3.19 Schematic Flowchart of Autodock Vina docking with multiplicity. 
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Figure 3.20 Success rate of AutoDock Vina docking on proteins in unbound v.s. 
bound state for the sub set containing Arg, Lys, Gln and Glu only. Success is defined 
as the percentage of the entire dataset that yields a prediction with one of the top five 
ranking pose predictions less than 2 Å away from the corresponding native pose. The 
blue represents the success rate of unbound docking (32.0%), while the green represents 
the success rate of bound docking (64.6%). 
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Figure 3.21 Scatterplot of Energy vs RMSD for the sub set containing Arg, Lys, Gln 
and Glu only. All data points are color coded by the rank of the pose prediction.  
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Figure 3.22 Flowchart of test set data collection 
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Appendix 
Computational and Experimental Investigation into the Role of Carboxyl Terminus 
of Human Eukaryotic Initiation Factor 4A as An Anti-Cancer Drug Target 
 
A.1 Introduction 
Gene expression is regulated at multiple levels, including the transcription of 
DNA sequence into mRNA, and the translation of mRNA into proteins. They both 
possess intricate regulation to assure the efficiency as well as the accuracy. Compared to 
transcriptional regulation, translational control has an advantage, allowing for rapid 
changes in the concentration of the protein. Thus, it is advantageous for the maintenance 
of cellular homeostasis as compared to permanent changes to cells. Numerous 
publications(85) have already shown that control of translation is crucial for cellular 
proliferation, development, apoptosis and transformation (cancer).  
Translation by definition represents the process of assembly of proteins, with 
diverse ribosomal complexes as assemblers, and amino acids as assembly units. The 
whole process can be divided into four main stages: initiation, elongation, termination, 
and ribosome recycling. Most translational regulations happen at the initiation stage, 
where the start codon is identified and attached by the methionyl tRNA (Met-tRNA). In 
eukaryotes, the start codon is identified by a scanning mechanism(86). Generally, the 
small ribosomal subunit (40S) binds with Met-tRNA and other cofactors to form a pre-
initiation complex (PIC). At the same time, a complex called eIF4F forms, then binds and 
unwinds the secondary structure of mRNA at the 5¢ end via its helicase activity. 
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Afterward, the PIC binds and scans the 5¢ untranslated region (5¢ UTR) for an ‘AUG’ 
codon. The set of proteins termed eukaryotic initiation factors (eIFs) plays crucial and 
diverse functions at the stage of initiation.  
 
 
Figure A.1 The eIF4F-signaling pathway (2). 
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Figure A.2 Disrupting assembly of a functional eIF4F hetero-trimer (2). A and B, 
deconstruction of eIF4F. A, disrupting association of eIF4E and eIF4G; B, disrupting 
association of eIF4A and eIF4G. C and D, targeting cap recognition. C, decreasing 
abundance of eIF4E; D, inhibiting the interaction between eIF4E and the mRNA cap. 4E, 
eIF4E; 4A, eIF4A; 4G, eIF4G. 
  
  
101 
In one example of initiation control, eIF1, 1A, 2, 3 and 5 are all recruited to the 
capped 5¢ end of mRNA. The eIF4E is the cap-binding factor(86). The eIF4G and eIF4A 
in the eIF4F complex (Figure A.4) facilitate the binding and unwinding of the mRNA 5¢ 
terminal secondary structure. Among all these factors, the eIF4F complex has been 
shown to be one of the most efficient machines of translation regulation. It is comprised 
of the ATP-dependent RNA helicase eIF4A, the adaptor protein eIF4G, and the 5¢-cap-
binding protein eIF4E.  
The eIF4A is a prototypic member of the DEAD-box family of proteins, a 
subgroup in the large superfamily of helicase(87). Three isoforms of eIF4A exist. The 
eIF4A I and II share 95% amino acid similarity and similar function in the initiation of 
translation. The third isoform, eIF4A III shares only 65% similarity to the other isoforms 
and is believed to be involved in pre-mRNA splicing as a core component of the exon 
junction complex. Generally, eIF4A III consists of two α/β domains with a RecA-like 
topology (88). The N-terminus and C-terminus are connected by a short segment of 
peptide, constituting a dumbbell-like arrangement. DEAD box helicase is characterized 
by nine conserved motifs: Q, I, Ia, Ib, II, III, IV, V, and VI, which are clustered in a 
tightly-packed	central core region, and were shown to be involved in the ATPase and 
helicase activities as well as the RNA binding (89, 90). Each of these motifs has its own 
role assigned based on analysis of crystal structures, genetic data, and biochemical 
experiments.  
The eIF4F complex is critical not only for its central role in the cap-dependent 
translation initiation, but also for its engagement in oncogenic pathways, and cancer cell 
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proliferation. It is well supported that the primary regulation of eIF4F activity is exerted 
through the PI3K/Akt/mTORC1/S6K/4E-BP signaling pathway, but other oncogenic 
pathways converge to the translational machinery mediated by the initiation complex 4F 
(Figure A.1). When activated, eIF4F reprograms the cellular translational machinery to 
amplify oncogenic signals and promote neoplastic capabilities in cancer cells as a mode 
of positive feedback. Evidence has shown that the mRNAs most sensitive to the activity 
of eIF4F are those encoding proteins that regulate hallmark capabilities of cancer cells. 
These include the mRNAs for growth factors and cytokines (fibroblast growth factor 2, 
insulin-like growth factor II, platelet-derived growth factor, TGF-β, VEGF, interleukin 
15, Wnt/β-catenin), protein kinases (Mos, Pim-1), transcription factors (Fos, Myc), 
inhibitors of apoptosis (surviving, Bcl-2, Bcl-Xl), and promoters of cell-cycle transit 
(Ras, Cdk4, cyclin D1) (91-93). Thus, eIF4F is usurped by many cancers, and functions 
as a pivotal regulatory hub where multiple oncogenic pathways converge.  
Given the central role of the eIF4F on oncogenic activation, it is practical to treat 
it as a potential target for rational drug design. To date, at least two different approaches 
for interfering with the eIF4F activity have been reported (Figure A.2): 1) disrupting the 
integrity of eIF4F and 2) antagonizing the eIF4E-mRNA-cap interaction. For instance, a 
research group led by Gerhard Wagner identified a compound 4EGI-1 (Figure A.3 
A)(94), which attenuates the expression of the oncoproteins, c-Myc and Bcl-XL. More 
recently, Pelletier and colleagues identified a nontoxic small-molecule inhibitor of the 
eIF4E-to-eIF4G association, 4E1RCat (Figure A.3 B) with promising therapeutic 
characteristics(95). A natural product, the plant cyclopenta[b]benzofuran flavagline 
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silvestrol (Figure A.3 C), acts as a chemical inducer of dimerization, depletes the 
intracellular repertoire of eIF4A by promoting interaction between eIF4A and RNA, and 
inhibits cancer cell growth by inducing mitochondrion-dependent apoptosis(96, 97). 
Other than direct interference, approaches targeting the eIF4E-mRNA-cap interaction are 
also actively investigated. Graff and colleagues from the Lilly Research Laboratory 
successfully applied an antisense oligonucleotide (ASO) –based strategy to down-
regulate eIF4E and suppress tumorigenesis without any signs of toxicity(98).  
Fragment-based drug design has grown significantly over the past decade with the 
advent of highly sensitive biophysical methods, such as X-ray Crystallography, NMR, 
ITC, SPR, etc.(99-101). A library of the fragment-sized small molecule is screened to 
reach an initial subset of fragment hits with relatively high ligand efficiency (LE) and 
specificity. Ligand efficiency is defined as the free energy change per heavy atom upon 
binding(102, 103). Further investigation could be performed to evaluate the potential of 
either growing or linking initial hits into potent larger drug-like leads. Protein hot spots 
represent the regions on the protein where interactions with a ligand contribute 
substantially to binding free energy. They energetically favor small molecule binding due 
to its features of spatial tightness, hydrophobicity, and capability of hydrogen 
bonding(104), compared to other regions. It has been recently reported that a very simple 
condition can be used to determine how fragment hits coincide with hot spots. The 
condition can be used to screen and identify stable binding fragments whose binding 
modes could be conserved upon subsequent expansion to a larger ligand(105). As shown 
in Figure A.5, preliminary solvent mapping on the eIF4A-CTD using FTMap shows that 
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there are two adjacent, hot spot cluster rich pocket regions on the minor interaction site 
with eIF4G. We posit that interrupting the eIF4A-eIF4G interaction on these hot spot 
cluster rich pocket regions has its physiological relevance. Hence, the goal of this study is 
to design potent inhibitors with FBDD strategy, targeting the ‘hot’ pocket region of 
eIF4A-CTD. We used both the computational approaches of docking and the 
experimental methods of NMR HSQC and X-ray crystallography to screen small 
molecule libraries for good fragment hits, followed by validation. 
Firstly, a virtual screen of a CMLD fragment library with 287 molecules (MW < 
300) was performed on each of the two pocket regions using a state-of-art docking tool, 
Autodock Vina. Then, we focused on twelve fragments which bear energetically 
favorable docking poses, good atomic interactions to the pocket regions and extensibility 
for further modification. The twelve fragments were split into three cocktail groups and 
subjected to a semi high-throughput NMR HSQC screen. For the groups showing 
significant chemical shift change, further NMR HSQC was performed for each fragment 
in the group to validate the interaction. Two chemotypes were found interacting with 
eIF4A-CTD, AP3 and Spirooxindole. 9 more compounds of AP3 chemotype were 
cherry-picked and tested for binding in a similar way. Unfortunately, they showed no 
binding activity due to the poor solubility. Hence, an alternative set of ten compounds in 
stock, more soluble due to sub-moiety replacement, were tested and six were found to 
bind to eIF4A-CTD, as shown in the “Results and Discussion” section.  
X-ray crystallography is a high-resolution method that can determine the three-
dimensional structure of both free protein and protein-ligand complex. It requires the 
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substance of interest in perfect crystalline form, which necessitates heavy screening of 
optimal crystallization conditions. Multiple screens were performed to identify the best 
crystallization conditions, using the screen kits from different sources, such as MCSG, 
Silver Bullet, etc. Each time a candidate condition was found to form a crystal in the 
satisfactory shape, a grid screen was followed to fine-tune the condition with the gradual 
expansions further. A few “crystals” formed as briefly discussed in the section “Result 
and Discussion”. Unfortunately, they were salt crystals as determined by initial screening 
via X-ray diffraction. Further optimization is needed for the formation of diffraction 
quality crystals.  
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Figure A.3 Chemical structures of the compounds as inhibitors of eIF4F 
activity. A, 4EGI-1; B, 4E1RCat; C, Silvestrol; D, Rocaglamide derivative 
 
Figure A.4 Schematic diagram of eIF4F complex 	
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Figure A.5 Schematic View of FTMap on eIF4A-CTD (green), together with 
RNA (orange), ANP (magenta), 4G tryptophan (yellow) and Hipporistanol (purple) 	 	
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A.2 Materials and Methods  
Protein expression and purification 
The expression vector (pET15) of the C-terminal domain of human eIF4A (amino 
acids 237 - 406) with a mutation (T298K) is a generous gift provided by Professor 
Gerhard Wagner from Harvard Medical School. An 8x His-tag is located at the N-
terminal of the expression vector. The single site variant was mutated back to the wild 
type sequence using QuickChange Site-Directed Mutagenesis Kit. The wild type eIF4A-
CTD was transformed into the competent E. Coli strain Solu-BL21. After IPTG 
induction, unlabeled and labeled eIF4A-CTD were expressed for 3.5 hours at 37 °C. 
Bacterium was resuspended and lysed using a microfluidizer in a lysis buffer containing 
20mM Tris-Cl (pH 7.0), 500mM NaCl, 10mM imidazole, and 2mM DTT. The protein 
was then purified out of the lysate with a Ni Sepharose affinity column (HisTrap HP) 
using a FPLC system. The elution buffer contains 50mM Tris-Cl (pH 7.0), 500mM 
Imidazole, 500mM NaCl and 2.5mM DTT. The fractions bearing the purest target protein 
were collected and dialyzed in buffer 20mM Tris-Cl (pH 7.5), 300mM NaCl and 2mM 
DTT. For the expression of 15N-isotope labeling protein, 15NH4Cl was used as a sole 
nitrogen source. The M9 Minimal Medium was used for labeled protein preparation 
(Table A.1). 
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A) Recipe of Minimal Medium 
Volume (ml) Reagent 
754.7 ddH2O 
200 5X M9 Salts 
6 Vitamin mix: 5mg/ml Thiamin and Nicotinic Acid 
20 20% Glucose 
0.3 1M CaCl2 
10 100X trace elements 
2 1M MgSO4 
3 Biotin, 0.2 mg/ml 
4 NH4Cl, 0.25 g/ml 
 
B) M9 salts (5X): Final Volume, 1L 
Amount (g) Reagent 
34 Anhydrous Na2HPO4 
15 Anhydrous KH2PO4 
2.5 NaCl 
 
Table A.1 Recipe for M9 Minimal Medium 
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NMR HSQC 
NMR spectra were measured on a Bruker Avance III HD 500MHZ spectrometer 
equipped with a 5mm, 1H-13C/15N/D, Z-gradient, CPTCI CryoProbe, located in the Core 
Facility for Structural NMR Spectroscopy, Boston University Medical Campus. Spectra 
were processed and integrated with Bruker TopSpin software version 3.  
The following procedure was performed for NMR HSQC. Protein samples were 
dissolved in 20mM Tris-Cl (pH 7.5), 200mM NaCl, 2mM DTT and 10% D2O at the final 
concentration of 150µM. 4% DMSO was added to the control group of free proteins to 
match the 4% DMSO in the compound binding cocktails. HSQC experiments were 
performed at 298 K, by standard procedures including lock (90% H2O and 10% D2O), 
tuning, shimming (topshim), pulse calibration and experiments run with the parameters 
optimized by calibration.  
The software ‘Cara’ was used to organize and visualize the spectra from 
experiments. 
 
Semi high-throughput NMR Screen of CMLD Compounds 
 12 CMLD compounds were cherry-picked based on in-silico docking result 
(Autodock Vina) and combined into three cocktail groups as shown in Table A.2. 2D 
structures of these compound are shown in Figure A.6. Protein was dialyzed into the final 
NMR working buffer, 20mM Tris-Cl (pH 7.5), 200mM NaCl, 2mM DTT. NMR signal 
was measured for both free proteins (200 µM) with 4% DMSO and protein (200 µM) 
with one group of 4 compounds (1mM for each compound in the group, 4mM in total 
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with 4% DMSO). Given that chemical shift change was observed for all the three groups, 
HSQC NMR was performed for all 12 individual compounds, under the same condition, 
but the compound concentration increased to 4mM.  
 
Group Compounds 
I CMLD009025, CMLD009026, CMLD009768, CMLD010154 
II CMLD007229, CMLD007238, CMLD008363, CMLD008531 
III CMLD003497, CMLD006282, CMLD006486, CMLD007208 
 
Table A.2 CMLD compound groups for HSQC NMR screen 
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Figure A.6 Chemical structures of the 12 CMLD compounds screened 
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Affinity determination using NMR titration 
 NMR titration was used to determine the binding affinity of the individual CMLD 
compound binding to eIF4A-CTD. The NMR procedure was discussed previously in the 
section “NMR HSQC Method”. The NMR HSQC experiment was repeatedly performed 
at a titration of compound concentration, 100 µM, 200 µM, 400 µM, 800 µM and 
1600uM, as long as the compound is dissolvable. The chemical shift change was 
quantitatively calculated as in Excel and fitted in 
the model to retrieve the Kd 
in Prism 6. 
 
Crystallization 
eIF4A-CTD was subjected to multiple rounds of thermofluor screening, buffer 
condition screens including MCSG Suites 1-4 from Microlytic and Silver Bullets screen 
from Hampton Research. An initial buffer condition in MCSG suite, 0.2 M zinc Acetate, 
0.1M MES:NaOH pH6.0 and 15% (v/v) ethanol was identified. A subsequent grid screen 
was set for the fine-tuning of the condition, spanning both the pH (5.0 to 7.5) and 
concentration of precipitant (10.0% to 17.5%). Given that low pH was observed more 
suitable for crystal generation, we replaced the original buffer, MES by sodium acetate 
with lower buffer range of pH between 3.7 and 5.6. Under the new buffer condition, 0.2 
M zinc acetate, 0.1M sodium acetate, a grid screen was run throughout varying ranges of 
both pH (4.5 to 7.5) and concentration of precipitant (ethanol, 5.0% to 20.0%), at a 
protein concentration of 12 mg/ml. To further optimize the crystallization with additional 
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additives, the Silver Bullets screen from Hampton Research was applied using the 
optimal condition from the above grid screen, 12 mg/ml protein concentration, 0.2M zinc 
acetate, 0.1M sodium acetate (pH 4.5), 15% ethanol. Multiple sets of small molecule 
additives were found to stabilize the protein, resulting in well-formed crystals.  
 
A.3 Results and Discussion 
A.3.1 Protein expression and purification of heIF4AI-CTD 
 IPTG induced the expressions of unlabeled and 15N labeled wild type heIF4AI-
CTD. Protein was extracted and purified through FPLC. All the fractions were collected 
and subjected to SDS-PAGE electrophoresis for purity check as shown in Figure A.7. 
The purest fractions (>~90%) were pooled, dialyzed and aliquoted for stock. The yield of 
unlabeled protein was 20 – 30 mg from 2 L cell culture in LB medium. Almost 10 mg of 
15N labeled protein was purified from 2 L cell culture in minimum medium.  
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       1       2         3        4        5         6       7         8       9      10       11        12     13 
Figure A.7 eIF4A-CTD expression (FPLC). Lane 1: MW ladder; Lane 2: sample before 
FPLC; Lane 3 – 4: two FPLC flow-through fractions; Lane 5: Column washing fraction; 
Lane 6 – 13: Gradient elution fractions 
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A.3.2 Solvent mapping with FTMap 
 The C-terminal domain of the human eIF4AI structure (PDB ID: 3EIQ) was 
mapped globally using FTMap. Two adjacent hot spot cluster rich pocket regions were 
identified on the surface as shown in Figure A.8. The pocket on the left is a minor 
binding site of heIF4G. The two hydrophobic pockets are well occupied by three primary 
hot spot consensus clusters of sizes of 19, 17 and 14 respectively, which are druggable 
based on our condition for druggable site identification (cluster size > 16). Moreover, the 
feature of spatial proximity renders them good target sites for FBDD, allowing the initial 
anchor fragment hits to either link or grow into a larger drug-like lead. It is worthy of 
note that these hot spot clusters rich sites are far away from the well-known binding sites 
of RNA and ADP. Their potential roles on the inhibition of eIF4A helicase activity has 
not previously been studied extensively. 
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Figure A.8 Hot Spot Rich Pocket Regions Identified by FTMap 
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A.3.3 Crystallization 
Many crystallization screens were performed to attain optimized conditions for 
crystal formation, including the MCSG crystal screen suite (1-4) from Microlytic and 
Silver Bullets screen from Hampton Research. When a potential condition was identified 
due to the formation of a suboptimal crystal, a grid screen was followed to optimize the 
crystal in both shape and size. For instance, we found an interesting condition in MCSG 
screen, 0.2 M zinc Acetate, 0.1M MES:NaOH pH6.0 and 15% (v/v) ethanol. The 
condition yielded the initial crystal form separated from the surrounding precipitate as 
shown in Figure A.9. Grid screening was then performed, spanning both pH (5.0 to 7.5) 
and concentration of precipitant agent (ethanol: 10% to 17.5%). Screening achieved 
crystals with better morphology under the low pH 5.0 and high concentration of 
precipitant agent (ethanol 17.5%). Since low pH seems more favorable for crystallization 
and the pH 5.0 is already out of the buffer capacity range of the original buffering agent 
(MES), we decided to replace it with another buffering agent, sodium acetate and 
repeated the grid screening, allowing lower pH range (4.5 to 5.4). The initial crystals 
were formed under the condition of 12 mg/ml protein; 0.2 M zinc Acetate, 0.1 M sodium 
acetate (buffer), pH 4.5, and 5.0% or 15.0% ethanol (precipitant), as shown in Figure 
A.10. 
To further improve the crystals, the Silver Bullet screen was utilized to leverage a 
portfolio of small molecules and excipients for their ability to establish stabilizing, 
intermolecular, hydrogen bonding, hydrophobic and electrostatic interactions which 
promote crystallization. In Figure A.11, three conditions were found to improve crystal 
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formation respectively, A) 0.25% w/v Hexamminecobalt(III) chloride, 0.25% w/v 
Salicylamide, 0.25% w/v Sulfanilamide, 0.25% w/v Vanillic acid; B) 0.25% w/v 3,5-
Dinitrosalicylic acid, 0.25% w/v Salicylamide, 0.25% w/v 3-Aminosalicylic acid, 0.25% 
w/v Sodium 1-pentanesulfonate monohydrate; C) 0.25% w/v 4-Aminobutyric acid, 
0.25% w/v Salicylamide, 0.25% w/v Cytosine, 0.25% w/v Sodium 1-pentanesulfonate 
monohydrate. The crystals were hence tested for diffraction in the X-ray beam. The 
diffraction pattern showed that unfortunately these are salt crystals, not protein. 
Crystallization of eIF4A-CTD was so far unsuccessful, probably because the C-
terminal domain of human eIF4A itself is relatively disordered in the absence of its N-
terminal counterpart. In the future, multiple approaches should be tested, including 1) co-
crystallization with those potent CMLD compounds from NMR screen; 2) preliminary 
filtration of library compounds with technique like thermal shift assay, a fast method that 
finds protein stabilizing conditions; 3) crystallization of full length eIF4A protein, which 
is more stable than the C-terminus alone. 
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Day1      Day 12 
Figure A.9 Initial Hit from MCSG screen. Buffer condition:  0.2 M zinc acetate, 0.1M 
MES:NaOH pH6.0 and 15% (v/v) ethanol. 
 
 
 
 
 
 
  
Figure A.10 Grid Screening. Condition: protein concentration, 12 mg/ml; 0.2 M zinc 
acetate, 0.1 M sodium acetate, pH 4.5, A)5.0% ethanol; B) 15.0% ethanol.  
A       B 
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Figure A.11 Index Screen. Condition: protein concentration: 11 mg / ml, 0.2 M zinc 
acetate, 01 M sodium acetate (pH 4.5), 15% ethanol. A) 0.25% w/v hexamminecobalt(III) 
chloride, 0.25% w/v salicylamide, 0.25% w/v sulfanilamide, 0.25% w/v vanillic acid; B) 
0.25% w/v 3,5-dinitrosalicylic acid, 0.25% w/v salicylamide, 0.25% w/v 3-aminosalicylic 
acid, 0.25% w/v sodium 1-pentanesulfonate monohydrate; C) 0.25% w/v 4-aminobutyric 
acid, 0.25% w/v salicylamide, 0.25% w/v cytosine, 0.25% w/v sodium 1-
pentanesulfonate monohydrate. 
  
  
           A         B     C 
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A.3.4 CMLD Library Screen using HSQC NMR 
 For its ultimate success, fragment-based drug discovery usually starts with anchor 
binders with high ligand efficiency. Our previous study on ligand deconstruction shows 
that the good overlap between fragment binders and primary hot spot clusters is a 
sufficient condition for the binding mode conservation.(105) Hence, to attain a set of 
optimal anchor fragment binders for the pocket regions identified previously by FTMap, 
we applied a combined strategy, incorporating both in-silico docking and semi high-
throughput NMR HSQC screen, followed by final validation by NMR. Thanks to my 
colleague, Zhuyezi Sun, who harnessed Autodock Vina to perform the local docking of a 
subset of 287 small fragments (MW < 300 kDa) from the CMLD library on the two hot 
spot cluster rich pockets were mapped. The subsequent investigation into the top-ranking 
docking poses in terms of the factors like docking energy, atom-wise interaction with 
protein and extensibility, confirms a small set of twelve ‘best’ fragments (see in Table 
A.2 and Figure A.6). They were cherry-picked, grouped into three cocktail groups and 
subjected to a screen using NMR HSQC in a semi high-throughput manner as discussed 
in the “Materials and Methods” section. While the solubility varies for all these cherry-
picked fragments, all three cocktail groups caused obvious chemical shift change for 
residues in the two pocket regions as well as other regions, as shown in Figure A.12. 
Even though a certain level of subjectivity remained while identifying shifting peaks, the 
final set was reasonable after manual removal of both weak peaks at noise level and 
outliers that are not surrounded by other shifting peaks. The cocktail group 1 led to 
chemical shift change more specifically than the other two groups.  
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 Subsequently, NMR HSQC experiments were performed for each fragment in all 
three cocktail groups to determine the true binders. As a result, two chemotypes were 
found to bind, AP3 (e.g. CMLD007229) and Spirooxindole (e.g. CMLD009026). As 
shown in Figure A.13, the affected regions are highlighted in cyan, evidenced by strong 
peak shifts, superimposed by the top-ranking docking poses as well.  
 
 
 
     A           B              C 
Figure A.12 Chemical Shifting Change Caused by 3 Cocktail Groups, A) Group 1 
(CMLD009025, CMLD009026, CMLD009768, CMLD010154); B) Group 2 
(CMLD007229, CMLD007238, CMLD008363, CMLD008531); C) Group 
3(CMLD003497, CMLD006282, CMLD006486, CMLD007208) 
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Figure A.13 Chemical Shifting Change Caused by the Compounds of Two 
Chemotypes, AP3 (Left, CMLD007229) and Spirooxindole (Right, CMLD009026) 
 
 Moreover, we determined the dissociation constant of CMLD007229 using the 
NMR titration method. As shown in Figure A.14, the chemical shift of the residue I406 
was measured and quantitated (see Materials and Methods) at gradient compound 
concentrations, including 0 (control), 0.25, 0.5, 1, 2 and 4 mM. The chemical shift 
changes were fitted to a single site binding model, using a least-squares fitting search (see 
Materials and Methods) to find the value of Kd. With the semi perfect fitting (R2: 0.8215), 
we estimated the affinity Kd, approximately as 0.5 – 1 mM.  
 Due to both strong peak shift by AP3 compound binding (e.g., CMLD007229) 
and its feature of synthetic feasibility, we decided to focus on the compound derivatives 
present in the collection. Nine candidates were cherry-picked for NMR, based on the 
docking of 100 AP3 compounds in the collection as shown in Figure A.15. 
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Unfortunately, the NMR HSQC results show no binding activity at all, primarily because 
of their poor solubility in aqueous buffer. A further moiety substitution of the compound 
based on the top docking pose generated a test set of nine smaller candidate derivatives, 
which are predicted to be more soluble (CMLD007194, CMLD007228, CMLD007241, 
CMLD010259, CMLD010260, CMLD010261, CMLD010262, CMLD010263, 
CMLD010264). Out of the nine AP3 candidates, five showed binding activity with 
satisfactory solubility, as marked by the blue star in Figure A.16. In Figure A.17, the 
distribution of peak shift on the surface of eIF4A-CTD, affected by two candidate 
derivatives, CMLD010259 and CMLD010260, is shown. It was promising to obtain a set 
of soluble binders of AP3 chemotype evidenced by the recorded strong peak shifts, after 
multiple rounds of the screen. But, the bindings, unfortunately were not specific to the 
pocket regions of interest, but to other regions. In the future, further titration experiments 
are needed to not only separate the residues affected by a specific compound binding 
from others, but identify the actual binding sites with their affinity, for all the 
compounds. Hopefully, with the help of other high-resolution techniques, these 
compounds can eventually turn into larger, potent drug-like leads through the general 
path of rational fragment-based drug discovery. 
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Figure A.14 Determination of Binding Affinity of CMLD007229 using NMR 
Titration  
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Figure A.15 Nine Candidate Derivatives of CMLD007229  
  
128 
 
 
 
 
 
Figure A.16 A Set of AP3 Derivatives with Moiety Substitutions. All the compounds 
labeled by “star” are binders evidenced by NMR HSQC.  
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Figure A.17 Chemical Shifting Change Caused by the Two Compounds of AP3 
Chemotype: Left, CMLD010259; Right, CMLD010260 
 
 
 
 
 
CMLD010259 CMLD010260 
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